activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1650288	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Kd	nM	2600.0	CHEMBL3981	Homo sapiens	Kd	uM	2.6
	1650288	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Kd	nM	2600.0	CHEMBL3981	Homo sapiens	Kd	uM	2.6
	1650289	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	110.0	CHEMBL3981	Homo sapiens	Kd	uM	0.11
Not Active	1650290	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3981	Homo sapiens	Kd		
	1650291	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	640.0	CHEMBL3981	Homo sapiens	Kd	uM	0.64
Not Active	1650292	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3981	Homo sapiens	Kd		
	1650293	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1100.0	CHEMBL3981	Homo sapiens	Kd	uM	1.1
	1650294	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	140.0	CHEMBL3981	Homo sapiens	Kd	uM	0.14
Not Active	1650295	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3981	Homo sapiens	Kd		
Not Active	1650296	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3981	Homo sapiens	Kd		
	1651401	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.03	CHEMBL3981	Homo sapiens	Kd	uM	0.00003
Not Active	1651402	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL3981	Homo sapiens	Kd		
Not Active	1651403	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL3981	Homo sapiens	Kd		
Not Active	1651404	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL3981	Homo sapiens	Kd		
	1651405	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	7.1	CHEMBL3981	Homo sapiens	Kd	uM	0.0071
Not Active	1651406	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL3981	Homo sapiens	Kd		
Not Active	1651407	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3981	Homo sapiens	Kd		
	1651408	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	870.0	CHEMBL3981	Homo sapiens	Kd	uM	0.87
	1651409	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	83.0	CHEMBL3981	Homo sapiens	Kd	uM	0.083
	1651410	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2400.0	CHEMBL3981	Homo sapiens	Kd	uM	2.4
	1651411	CHEMBL860781	Average Binding Constant for STK10; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	430.0	CHEMBL3981	Homo sapiens	Kd	uM	0.43
	2147297	CHEMBL921982	Activity of human LOK kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	95.0	CHEMBL3981	Homo sapiens	Activity	%	95.0
	2206765	CHEMBL989730	Inhibition of STK10	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	83.0	CHEMBL3981	Homo sapiens	Kd	nM	83.0
	2206923	CHEMBL989730	Inhibition of STK10	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	140.0	CHEMBL3981	Homo sapiens	Kd	nM	140.0
	2393785	CHEMBL1004492	Binding affinity to human recombinant LOK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	<	Tm	degrees C	2.0	CHEMBL3981	Homo sapiens	Tm	degrees C	2.0
	2393786	CHEMBL1004492	Binding affinity to human recombinant LOK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	<	Tm	degrees C	2.0	CHEMBL3981	Homo sapiens	Tm	degrees C	2.0
	2393787	CHEMBL1004492	Binding affinity to human recombinant LOK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCC[C@@H](O)[C@@H](C)CC/C=C/2		CHEMBL454394	<	Tm	degrees C	2.0	CHEMBL3981	Homo sapiens	Tm	degrees C	2.0
	2393788	CHEMBL1004492	Binding affinity to human recombinant LOK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCCC(=O)[C@@H](C)CC/C=C/2		CHEMBL453389	<	Tm	degrees C	2.0	CHEMBL3981	Homo sapiens	Tm	degrees C	2.0
	2393789	CHEMBL1004492	Binding affinity to human recombinant LOK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc(O)c2c(c1)/C=C/CC[C@H](C)C(=O)CCC[C@H](C)OC2=O		CHEMBL510836	<	Tm	degrees C	2.0	CHEMBL3981	Homo sapiens	Tm	degrees C	2.0
	2393790	CHEMBL1004492	Binding affinity to human recombinant LOK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)CCC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL454173	=	Tm	degrees C	4.6	CHEMBL3981	Homo sapiens	Tm	degrees C	4.6
	2393791	CHEMBL1004492	Binding affinity to human recombinant LOK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)[C@@H](C)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL453375	<	Tm	degrees C	2.0	CHEMBL3981	Homo sapiens	Tm	degrees C	2.0
	2395449	CHEMBL961276	Binding affinity to LOK at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	10.0	CHEMBL3981	Homo sapiens	Activity	%	10.0
	2395468	CHEMBL963596	Inhibition of LOK by Ambit binding assay	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	IC50	nM	500.0	CHEMBL3981	Homo sapiens	IC50	nM	500.0
	2470215	CHEMBL983617	Inhibition of LOK at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3981	Homo sapiens	INH	%	10.0
	2476574	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	33.5	CHEMBL3981	Homo sapiens	Activity	%	33.5
Not Evaluated	2476777	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3981	Homo sapiens	Activity		
Not Evaluated	2478616	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3981	Homo sapiens	Activity		
	2478819	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	4.8	CHEMBL3981	Homo sapiens	Activity	%	4.8
	2479674	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	13.0	CHEMBL3981	Homo sapiens	Activity	%	13.0
Active	2480674	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL3981	Homo sapiens	Activity		
	2558433	CHEMBL989976	Inhibition of LOK	B	Cc1ccc(NC(=O)c2ccnc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476141	>	IC50	nM	10000.0	CHEMBL3981	Homo sapiens	IC50	uM	10.0
Not Evaluated	2577295	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3981	Homo sapiens	Activity		
Not Evaluated	2577498	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3981	Homo sapiens	Activity		
	2593500	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	0.2	CHEMBL3981	Homo sapiens	Activity	%	0.2
	2593703	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	17.4	CHEMBL3981	Homo sapiens	Activity	%	17.4
Active	2593969	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL3981	Homo sapiens	Activity		
Not Evaluated	2594912	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3981	Homo sapiens	Activity		
	2595115	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275	=	Activity	%	2.25	CHEMBL3981	Homo sapiens	Activity	%	2.25
	2595181	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	1.1	CHEMBL3981	Homo sapiens	Activity	%	1.1
	2596312	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	0.1	CHEMBL3981	Homo sapiens	Activity	%	0.1
	2597581	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	22.5	CHEMBL3981	Homo sapiens	Activity	%	22.5
Not Evaluated	2597784	CHEMBL992636	Binding affinity to human LOK at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3981	Homo sapiens	Activity		
	2721641	CHEMBL1057470	Inhibition of LOK at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	2897948	CHEMBL1051338	Binding constant for LOK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	460.0	CHEMBL3981	Homo sapiens	Kd	nM	460.0
	2897949	CHEMBL1051338	Binding constant for LOK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	1100.0	CHEMBL3981	Homo sapiens	Kd	nM	1100.0
	2897950	CHEMBL1051338	Binding constant for LOK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	0.92	CHEMBL3981	Homo sapiens	Kd	nM	0.92
	2897951	CHEMBL1051338	Binding constant for LOK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	2800.0	CHEMBL3981	Homo sapiens	Kd	nM	2800.0
	2897952	CHEMBL1051338	Binding constant for LOK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	12.0	CHEMBL3981	Homo sapiens	Kd	nM	12.0
	2897953	CHEMBL1051338	Binding constant for LOK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897954	CHEMBL1051338	Binding constant for LOK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	550.0	CHEMBL3981	Homo sapiens	Kd	nM	550.0
	2897955	CHEMBL1051338	Binding constant for LOK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	60.0	CHEMBL3981	Homo sapiens	Kd	nM	60.0
	2897956	CHEMBL1051338	Binding constant for LOK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1900.0	CHEMBL3981	Homo sapiens	Kd	nM	1900.0
	2897957	CHEMBL1051338	Binding constant for LOK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897958	CHEMBL1051338	Binding constant for LOK kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897959	CHEMBL1051338	Binding constant for LOK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1200.0	CHEMBL3981	Homo sapiens	Kd	nM	1200.0
	2897960	CHEMBL1051338	Binding constant for LOK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	330.0	CHEMBL3981	Homo sapiens	Kd	nM	330.0
	2897961	CHEMBL1051338	Binding constant for LOK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	19.0	CHEMBL3981	Homo sapiens	Kd	nM	19.0
	2897962	CHEMBL1051338	Binding constant for LOK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897963	CHEMBL1051338	Binding constant for LOK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	470.0	CHEMBL3981	Homo sapiens	Kd	nM	470.0
	2897964	CHEMBL1051338	Binding constant for LOK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897965	CHEMBL1051338	Binding constant for LOK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	84.0	CHEMBL3981	Homo sapiens	Kd	nM	84.0
	2897966	CHEMBL1051338	Binding constant for LOK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897967	CHEMBL1051338	Binding constant for LOK kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	110.0	CHEMBL3981	Homo sapiens	Kd	nM	110.0
	2897968	CHEMBL1051338	Binding constant for LOK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Kd	nM	4400.0	CHEMBL3981	Homo sapiens	Kd	nM	4400.0
	2897969	CHEMBL1051338	Binding constant for LOK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	280.0	CHEMBL3981	Homo sapiens	Kd	nM	280.0
	2897970	CHEMBL1051338	Binding constant for LOK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897971	CHEMBL1051338	Binding constant for LOK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3700.0	CHEMBL3981	Homo sapiens	Kd	nM	3700.0
	2897972	CHEMBL1051338	Binding constant for LOK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897973	CHEMBL1051338	Binding constant for LOK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	590.0	CHEMBL3981	Homo sapiens	Kd	nM	590.0
	2897974	CHEMBL1051338	Binding constant for LOK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897975	CHEMBL1051338	Binding constant for LOK kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897976	CHEMBL1051338	Binding constant for LOK kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897977	CHEMBL1051338	Binding constant for LOK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897978	CHEMBL1051338	Binding constant for LOK kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897979	CHEMBL1051338	Binding constant for LOK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	150.0	CHEMBL3981	Homo sapiens	Kd	nM	150.0
	2897980	CHEMBL1051338	Binding constant for LOK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.037	CHEMBL3981	Homo sapiens	Kd	nM	0.037
	2897981	CHEMBL1051338	Binding constant for LOK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	230.0	CHEMBL3981	Homo sapiens	Kd	nM	230.0
	2897982	CHEMBL1051338	Binding constant for LOK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	19.0	CHEMBL3981	Homo sapiens	Kd	nM	19.0
	2897983	CHEMBL1051338	Binding constant for LOK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	120.0	CHEMBL3981	Homo sapiens	Kd	nM	120.0
	2897984	CHEMBL1051338	Binding constant for LOK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	2897985	CHEMBL1051338	Binding constant for LOK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	81.0	CHEMBL3981	Homo sapiens	Kd	nM	81.0
	2921290	CHEMBL1049109	Inhibition of LOK assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	0.0	CHEMBL3981	Homo sapiens	Activity	%	0.0
	3213943	CHEMBL1114899	Inhibition of LOK at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	2.0	CHEMBL3981	Homo sapiens	INH	%	2.0
	3332000	CHEMBL1166050	Inhibition of LOK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	3333415	CHEMBL1166050	Inhibition of LOK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	3334820	CHEMBL1166050	Inhibition of LOK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	3336240	CHEMBL1166050	Inhibition of LOK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	3337569	CHEMBL1166050	Inhibition of LOK at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	3338900	CHEMBL1166050	Inhibition of LOK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	3339154	CHEMBL1166050	Inhibition of LOK at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	3340457	CHEMBL1166050	Inhibition of LOK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	3341782	CHEMBL1166050	Inhibition of LOK at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	66.0	CHEMBL3981	Homo sapiens	INH	%	66.0
	3343229	CHEMBL1166050	Inhibition of LOK at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	3358639	CHEMBL1174881	Inhibition of LOK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL3981	Homo sapiens	INH	%	0.0
	3359081	CHEMBL1174881	Inhibition of LOK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL3981	Homo sapiens	INH	%	0.0
	3407754	CHEMBL1219791	Inhibition of LOK at 1 uM by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	<	Inhibition	%	10.0	CHEMBL3981	Homo sapiens	INH	%	10.0
	3407755	CHEMBL1219791	Inhibition of LOK at 1 uM by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	<	Inhibition	%	10.0	CHEMBL3981	Homo sapiens	INH	%	10.0
	3444996	CHEMBL1244484	Binding affinity to LOK	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	9400.0	CHEMBL3981	Homo sapiens	Kd	nM	9400.0
	3445172	CHEMBL1244484	Binding affinity to LOK	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	5.7	CHEMBL3981	Homo sapiens	Kd	nM	5.7
	3446200	CHEMBL1244340	Inhibition of STK10	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	52.0	CHEMBL3981	Homo sapiens	IC50	nM	52.0
	3448477	CHEMBL1244484	Binding affinity to LOK	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	3448970	CHEMBL1244484	Binding affinity to LOK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	590.0	CHEMBL3981	Homo sapiens	Kd	nM	590.0
	3449253	CHEMBL1244484	Binding affinity to LOK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	19.0	CHEMBL3981	Homo sapiens	Kd	nM	19.0
	3449254	CHEMBL1244484	Binding affinity to LOK	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	150.0	CHEMBL3981	Homo sapiens	Kd	nM	150.0
	3451036	CHEMBL1244484	Binding affinity to LOK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	uM	10.0
	5120265	CHEMBL1646182	Inhibition of human LOK at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	89.0	CHEMBL3981	Homo sapiens	INH	%	89.0
	6341079	CHEMBL1828392	Activity of LOK kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3981	Homo sapiens	Activity	%	100.0
	6385718	CHEMBL1838173	Inhibition of human LOK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	6385719	CHEMBL1838173	Inhibition of human LOK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	6385720	CHEMBL1838173	Inhibition of human LOK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	6385721	CHEMBL1838173	Inhibition of human LOK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	6385722	CHEMBL1838173	Inhibition of human LOK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	7567428	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	23.0	CHEMBL3981	Homo sapiens	Kd	nM	23.0
	7567916	CHEMBL1908727	Binding constant for LOK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	13.0	CHEMBL3981	Homo sapiens	Kd	nM	13.0
	7568384	CHEMBL1908727	Binding constant for LOK kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	1800.0	CHEMBL3981	Homo sapiens	Kd	nM	1800.0
	7568816	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	230.0	CHEMBL3981	Homo sapiens	Kd	nM	230.0
	7569419	CHEMBL1908727	Binding constant for LOK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7569891	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7570354	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	290.0	CHEMBL3981	Homo sapiens	Kd	nM	290.0
	7570781	CHEMBL1908727	Binding constant for LOK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	19.0	CHEMBL3981	Homo sapiens	Kd	nM	19.0
	7570935	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7571392	CHEMBL1908727	Binding constant for LOK kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	44.0	CHEMBL3981	Homo sapiens	Kd	nM	44.0
	7571868	CHEMBL1908727	Binding constant for LOK kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7572331	CHEMBL1908727	Binding constant for LOK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7572747	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	82.0	CHEMBL3981	Homo sapiens	Kd	nM	82.0
	7572916	CHEMBL1908727	Binding constant for LOK kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	4900.0	CHEMBL3981	Homo sapiens	Kd	nM	4900.0
	7573373	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1200.0	CHEMBL3981	Homo sapiens	Kd	nM	1200.0
	7573849	CHEMBL1908727	Binding constant for LOK kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	1700.0	CHEMBL3981	Homo sapiens	Kd	nM	1700.0
	7574318	CHEMBL1908727	Binding constant for LOK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	590.0	CHEMBL3981	Homo sapiens	Kd	nM	590.0
	7574726	CHEMBL1908727	Binding constant for LOK kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7574894	CHEMBL1908727	Binding constant for LOK kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	87.0	CHEMBL3981	Homo sapiens	Kd	nM	87.0
	7575355	CHEMBL1908727	Binding constant for LOK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	19.0	CHEMBL3981	Homo sapiens	Kd	nM	19.0
	7575826	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	22.0	CHEMBL3981	Homo sapiens	Kd	nM	22.0
	7576291	CHEMBL1908727	Binding constant for LOK kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7576868	CHEMBL1908727	Binding constant for LOK kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	4300.0	CHEMBL3981	Homo sapiens	Kd	nM	4300.0
	7577327	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	0.53	CHEMBL3981	Homo sapiens	Kd	nM	0.53
	7577805	CHEMBL1908727	Binding constant for LOK kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	13.0	CHEMBL3981	Homo sapiens	Kd	nM	13.0
	7578238	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2900.0	CHEMBL3981	Homo sapiens	Kd	nM	2900.0
	7578876	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7579250	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	12.0	CHEMBL3981	Homo sapiens	Kd	nM	12.0
	7579700	CHEMBL1908727	Binding constant for LOK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7580201	CHEMBL1908727	Binding constant for LOK kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	77.0	CHEMBL3981	Homo sapiens	Kd	nM	77.0
	7580604	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	81.0	CHEMBL3981	Homo sapiens	Kd	nM	81.0
	7581234	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7581619	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7582064	CHEMBL1908727	Binding constant for LOK kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	=	Kd	nM	1300.0	CHEMBL3981	Homo sapiens	Kd	nM	1300.0
	7582093	CHEMBL1908727	Binding constant for LOK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Kd	nM	4400.0	CHEMBL3981	Homo sapiens	Kd	nM	4400.0
	7582557	CHEMBL1908727	Binding constant for LOK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7582957	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	120.0	CHEMBL3981	Homo sapiens	Kd	nM	120.0
	7583580	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	460.0	CHEMBL3981	Homo sapiens	Kd	nM	460.0
	7583977	CHEMBL1908727	Binding constant for LOK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7584451	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7584913	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	70.0	CHEMBL3981	Homo sapiens	Kd	nM	70.0
	7585317	CHEMBL1908727	Binding constant for LOK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7586322	CHEMBL1908727	Binding constant for LOK kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7586793	CHEMBL1908727	Binding constant for LOK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	280.0	CHEMBL3981	Homo sapiens	Kd	nM	280.0
	7587247	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	380.0	CHEMBL3981	Homo sapiens	Kd	nM	380.0
	7587429	CHEMBL1908727	Binding constant for LOK kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	2100.0	CHEMBL3981	Homo sapiens	Kd	nM	2100.0
	7587848	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	220.0	CHEMBL3981	Homo sapiens	Kd	nM	220.0
	7588301	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	470.0	CHEMBL3981	Homo sapiens	Kd	nM	470.0
	7588772	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7589223	CHEMBL1908727	Binding constant for LOK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7589394	CHEMBL1908727	Binding constant for LOK kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1200.0	CHEMBL3981	Homo sapiens	Kd	nM	1200.0
	7589818	CHEMBL1908727	Binding constant for LOK kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	5.7	CHEMBL3981	Homo sapiens	Kd	nM	5.7
	7590285	CHEMBL1908727	Binding constant for LOK kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7590759	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	9500.0	CHEMBL3981	Homo sapiens	Kd	nM	9500.0
	7591210	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7591367	CHEMBL1908727	Binding constant for LOK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	1100.0	CHEMBL3981	Homo sapiens	Kd	nM	1100.0
	7591789	CHEMBL1908727	Binding constant for LOK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	550.0	CHEMBL3981	Homo sapiens	Kd	nM	550.0
	7592261	CHEMBL1908727	Binding constant for LOK kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	69.0	CHEMBL3981	Homo sapiens	Kd	nM	69.0
	7592734	CHEMBL1908727	Binding constant for LOK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3700.0	CHEMBL3981	Homo sapiens	Kd	nM	3700.0
	7593334	CHEMBL1908727	Binding constant for LOK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	0.92	CHEMBL3981	Homo sapiens	Kd	nM	0.92
	7593769	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	60.0	CHEMBL3981	Homo sapiens	Kd	nM	60.0
	7594241	CHEMBL1908727	Binding constant for LOK kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7594724	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	7.0	CHEMBL3981	Homo sapiens	Kd	nM	7.0
	7595302	CHEMBL1908727	Binding constant for LOK kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7595746	CHEMBL1908727	Binding constant for LOK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1900.0	CHEMBL3981	Homo sapiens	Kd	nM	1900.0
	7596220	CHEMBL1908727	Binding constant for LOK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7596249	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	6800.0	CHEMBL3981	Homo sapiens	Kd	nM	6800.0
	7596696	CHEMBL1908727	Binding constant for LOK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	150.0	CHEMBL3981	Homo sapiens	Kd	nM	150.0
	7597274	CHEMBL1908727	Binding constant for LOK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	2800.0	CHEMBL3981	Homo sapiens	Kd	nM	2800.0
	7597727	CHEMBL1908727	Binding constant for LOK kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3981	Homo sapiens	Kd	nM	10000.0
	7598228	CHEMBL1908727	Binding constant for LOK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	84.0	CHEMBL3981	Homo sapiens	Kd	nM	84.0
	7598670	CHEMBL1908727	Binding constant for LOK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.037	CHEMBL3981	Homo sapiens	Kd	nM	0.037
	7922688	CHEMBL1918458	Inhibition of human recombinant LOK at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	37.0	CHEMBL3981	Homo sapiens	INH	%	37.0
	7996705	CHEMBL1944036	Inhibition of LOK at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	97.0	CHEMBL3981	Homo sapiens	INH	%	97.0
	8004264	CHEMBL1942770	Inhibition of human LOK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	8004265	CHEMBL1942770	Inhibition of human LOK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	8004266	CHEMBL1942770	Inhibition of human LOK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	8004267	CHEMBL1942770	Inhibition of human LOK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	8047172	CHEMBL1959398	Inhibition of STK10 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	8061334	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.42	CHEMBL3981	Homo sapiens	Inhibition	%	1.42
	8061511	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	5.71	CHEMBL3981	Homo sapiens	Inhibition	%	5.71
	8061842	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	8.59	CHEMBL3981	Homo sapiens	Inhibition	%	8.59
	8062033	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.81	CHEMBL3981	Homo sapiens	Inhibition	%	3.81
	8062373	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.28	CHEMBL3981	Homo sapiens	Inhibition	%	4.28
	8062535	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	13.52	CHEMBL3981	Homo sapiens	Inhibition	%	13.52
	8062857	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	4.14	CHEMBL3981	Homo sapiens	Inhibition	%	4.14
	8063213	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	23.69	CHEMBL3981	Homo sapiens	Inhibition	%	23.69
	8063380	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.44	CHEMBL3981	Homo sapiens	Inhibition	%	4.44
	8063712	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.27	CHEMBL3981	Homo sapiens	Inhibition	%	6.27
	8063894	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	11.96	CHEMBL3981	Homo sapiens	Inhibition	%	11.96
	8064233	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	7.08	CHEMBL3981	Homo sapiens	Inhibition	%	7.08
	8064443	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.67	CHEMBL3981	Homo sapiens	Inhibition	%	1.67
	8064805	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-1.08	CHEMBL3981	Homo sapiens	Inhibition	%	-1.08
	8064971	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	10.54	CHEMBL3981	Homo sapiens	Inhibition	%	10.54
	8065195	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	4.51	CHEMBL3981	Homo sapiens	Inhibition	%	4.51
	8065311	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.54	CHEMBL3981	Homo sapiens	Inhibition	%	3.54
	8065486	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.84	CHEMBL3981	Homo sapiens	Inhibition	%	3.84
	8065710	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	19.75	CHEMBL3981	Homo sapiens	Inhibition	%	19.75
	8065825	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.62	CHEMBL3981	Homo sapiens	Inhibition	%	2.62
	8066035	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	6.26	CHEMBL3981	Homo sapiens	Inhibition	%	6.26
	8066259	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.01	CHEMBL3981	Homo sapiens	Inhibition	%	-0.01
	8066395	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	11.24	CHEMBL3981	Homo sapiens	Inhibition	%	11.24
	8066785	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	8.53	CHEMBL3981	Homo sapiens	Inhibition	%	8.53
	8066909	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	20.49	CHEMBL3981	Homo sapiens	Inhibition	%	20.49
	8067133	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	34.23	CHEMBL3981	Homo sapiens	Inhibition	%	34.23
	8067308	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.49	CHEMBL3981	Homo sapiens	Inhibition	%	3.49
	8067429	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	5.59	CHEMBL3981	Homo sapiens	Inhibition	%	5.59
	8067653	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.07	CHEMBL3981	Homo sapiens	Inhibition	%	2.07
	8067863	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.09	CHEMBL3981	Homo sapiens	Inhibition	%	3.09
	8067998	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	5.8	CHEMBL3981	Homo sapiens	Inhibition	%	5.8
	8068222	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	27.27	CHEMBL3981	Homo sapiens	Inhibition	%	27.27
	8068386	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.27	CHEMBL3981	Homo sapiens	Inhibition	%	2.27
	8068735	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.11	CHEMBL3981	Homo sapiens	Inhibition	%	3.11
	8068909	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	10.55	CHEMBL3981	Homo sapiens	Inhibition	%	10.55
	8069258	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.79	CHEMBL3981	Homo sapiens	Inhibition	%	1.79
	8069553	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	8.17	CHEMBL3981	Homo sapiens	Inhibition	%	8.17
	8069714	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.84	CHEMBL3981	Homo sapiens	Inhibition	%	3.84
	8070064	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	6.81	CHEMBL3981	Homo sapiens	Inhibition	%	6.81
	8070236	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	36.01	CHEMBL3981	Homo sapiens	Inhibition	%	36.01
	8070585	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.88	CHEMBL3981	Homo sapiens	Inhibition	%	0.88
	8070883	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	47.04	CHEMBL3981	Homo sapiens	Inhibition	%	47.04
	8071040	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.5	CHEMBL3981	Homo sapiens	Inhibition	%	1.5
	8071264	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	7.34	CHEMBL3981	Homo sapiens	Inhibition	%	7.34
	8071390	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.36	CHEMBL3981	Homo sapiens	Inhibition	%	3.36
	8071563	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	78.44	CHEMBL3981	Homo sapiens	Inhibition	%	78.44
	8071787	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	6.48	CHEMBL3981	Homo sapiens	Inhibition	%	6.48
	8071912	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.62	CHEMBL3981	Homo sapiens	Inhibition	%	0.62
	8072226	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	4.04	CHEMBL3981	Homo sapiens	Inhibition	%	4.04
	8072607	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	9.63	CHEMBL3981	Homo sapiens	Inhibition	%	9.63
	8072732	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	7.9	CHEMBL3981	Homo sapiens	Inhibition	%	7.9
	8073123	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	11.31	CHEMBL3981	Homo sapiens	Inhibition	%	11.31
	8073248	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	24.5	CHEMBL3981	Homo sapiens	Inhibition	%	24.5
	8073472	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	55.42	CHEMBL3981	Homo sapiens	Inhibition	%	55.42
	8073591	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.32	CHEMBL3981	Homo sapiens	Inhibition	%	0.32
	8073824	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	12.5	CHEMBL3981	Homo sapiens	Inhibition	%	12.5
	8074200	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	14.65	CHEMBL3981	Homo sapiens	Inhibition	%	14.65
	8074330	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	12.93	CHEMBL3981	Homo sapiens	Inhibition	%	12.93
	8074554	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	55.79	CHEMBL3981	Homo sapiens	Inhibition	%	55.79
	8074711	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.78	CHEMBL3981	Homo sapiens	Inhibition	%	3.78
	8075062	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.54	CHEMBL3981	Homo sapiens	Inhibition	%	1.54
	8075173	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.53	CHEMBL3981	Homo sapiens	Inhibition	%	3.53
	8075410	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.82	CHEMBL3981	Homo sapiens	Inhibition	%	-1.82
	8075634	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.24	CHEMBL3981	Homo sapiens	Inhibition	%	1.24
	8075775	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.75	CHEMBL3981	Homo sapiens	Inhibition	%	4.75
	8076141	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	35.22	CHEMBL3981	Homo sapiens	Inhibition	%	35.22
	8076289	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.45	CHEMBL3981	Homo sapiens	Inhibition	%	5.45
	8076647	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.74	CHEMBL3981	Homo sapiens	Inhibition	%	0.74
	8076749	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.1	CHEMBL3981	Homo sapiens	Inhibition	%	1.1
	8076973	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.83	CHEMBL3981	Homo sapiens	Inhibition	%	3.83
	8077220	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.16	CHEMBL3981	Homo sapiens	Inhibition	%	1.16
	8077348	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	6.92	CHEMBL3981	Homo sapiens	Inhibition	%	6.92
	8077723	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	80.74	CHEMBL3981	Homo sapiens	Inhibition	%	80.74
	8077866	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	24.98	CHEMBL3981	Homo sapiens	Inhibition	%	24.98
	8078090	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	66.74	CHEMBL3981	Homo sapiens	Inhibition	%	66.74
	8078229	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.42	CHEMBL3981	Homo sapiens	Inhibition	%	-0.42
	8078555	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	19.7	CHEMBL3981	Homo sapiens	Inhibition	%	19.7
	8078805	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	19.75	CHEMBL3981	Homo sapiens	Inhibition	%	19.75
	8078921	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.18	CHEMBL3981	Homo sapiens	Inhibition	%	4.18
	8079145	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.45	CHEMBL3981	Homo sapiens	Inhibition	%	5.45
	8079303	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	48.12	CHEMBL3981	Homo sapiens	Inhibition	%	48.12
	8079669	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.71	CHEMBL3981	Homo sapiens	Inhibition	%	2.71
	8079808	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	16.42	CHEMBL3981	Homo sapiens	Inhibition	%	16.42
	8080137	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	63.56	CHEMBL3981	Homo sapiens	Inhibition	%	63.56
	8080389	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-1.08	CHEMBL3981	Homo sapiens	Inhibition	%	-1.08
	8080728	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.51	CHEMBL3981	Homo sapiens	Inhibition	%	4.51
	8080892	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	85.74	CHEMBL3981	Homo sapiens	Inhibition	%	85.74
	8081251	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	6.62	CHEMBL3981	Homo sapiens	Inhibition	%	6.62
	8081395	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	7.74	CHEMBL3981	Homo sapiens	Inhibition	%	7.74
	8081619	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	29.22	CHEMBL3981	Homo sapiens	Inhibition	%	29.22
	8081722	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	6.26	CHEMBL3981	Homo sapiens	Inhibition	%	6.26
	8081974	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	12.59	CHEMBL3981	Homo sapiens	Inhibition	%	12.59
	8082311	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	9.23	CHEMBL3981	Homo sapiens	Inhibition	%	9.23
	8082484	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.78	CHEMBL3981	Homo sapiens	Inhibition	%	-0.78
	8082708	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.14	CHEMBL3981	Homo sapiens	Inhibition	%	4.14
	8082831	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.19	CHEMBL3981	Homo sapiens	Inhibition	%	2.19
	8083211	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	6.25	CHEMBL3981	Homo sapiens	Inhibition	%	6.25
	8083310	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	46.33	CHEMBL3981	Homo sapiens	Inhibition	%	46.33
	8083534	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.13	CHEMBL3981	Homo sapiens	Inhibition	%	3.13
	8083564	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.39	CHEMBL3981	Homo sapiens	Inhibition	%	0.39
	8083788	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	18.35	CHEMBL3981	Homo sapiens	Inhibition	%	18.35
	8083898	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.39	CHEMBL3981	Homo sapiens	Inhibition	%	3.39
	8084307	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	4.44	CHEMBL3981	Homo sapiens	Inhibition	%	4.44
	8084425	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	6.8	CHEMBL3981	Homo sapiens	Inhibition	%	6.8
	8084649	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	6.27	CHEMBL3981	Homo sapiens	Inhibition	%	6.27
	8084810	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	12.21	CHEMBL3981	Homo sapiens	Inhibition	%	12.21
	8085132	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	10.19	CHEMBL3981	Homo sapiens	Inhibition	%	10.19
	8085388	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-4.65	CHEMBL3981	Homo sapiens	Inhibition	%	-4.65
	8085496	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	5.28	CHEMBL3981	Homo sapiens	Inhibition	%	5.28
	8085720	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.62	CHEMBL3981	Homo sapiens	Inhibition	%	2.62
	8085909	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	13.12	CHEMBL3981	Homo sapiens	Inhibition	%	13.12
	8086248	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	13.89	CHEMBL3981	Homo sapiens	Inhibition	%	13.89
	8086410	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.1	CHEMBL3981	Homo sapiens	Inhibition	%	4.1
	8086733	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.02	CHEMBL3981	Homo sapiens	Inhibition	%	2.02
	8086944	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	6.82	CHEMBL3981	Homo sapiens	Inhibition	%	6.82
	8087326	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.74	CHEMBL3981	Homo sapiens	Inhibition	%	1.74
	8087440	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	83.01	CHEMBL3981	Homo sapiens	Inhibition	%	83.01
	8087664	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	8.13	CHEMBL3981	Homo sapiens	Inhibition	%	8.13
	8087802	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	56.81	CHEMBL3981	Homo sapiens	Inhibition	%	56.81
	8088168	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	8.24	CHEMBL3981	Homo sapiens	Inhibition	%	8.24
	8088316	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.01	CHEMBL3981	Homo sapiens	Inhibition	%	2.01
	8088668	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	53.99	CHEMBL3981	Homo sapiens	Inhibition	%	53.99
	8088985	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	6.5	CHEMBL3981	Homo sapiens	Inhibition	%	6.5
	8089113	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.06	CHEMBL3981	Homo sapiens	Inhibition	%	-0.06
	8089485	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.18	CHEMBL3981	Homo sapiens	Inhibition	%	1.18
	8089605	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	7.62	CHEMBL3981	Homo sapiens	Inhibition	%	7.62
	8089829	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.59	CHEMBL3981	Homo sapiens	Inhibition	%	2.59
	8090009	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	3.24	CHEMBL3981	Homo sapiens	Inhibition	%	3.24
	8090174	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.03	CHEMBL3981	Homo sapiens	Inhibition	%	2.03
	8090398	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.12	CHEMBL3981	Homo sapiens	Inhibition	%	5.12
	8090565	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.62	CHEMBL3981	Homo sapiens	Inhibition	%	4.62
	8090704	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	12.91	CHEMBL3981	Homo sapiens	Inhibition	%	12.91
	8090928	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	26.04	CHEMBL3981	Homo sapiens	Inhibition	%	26.04
	8091133	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.66	CHEMBL3981	Homo sapiens	Inhibition	%	5.66
	8091270	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	10.6	CHEMBL3981	Homo sapiens	Inhibition	%	10.6
	8091494	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	8.52	CHEMBL3981	Homo sapiens	Inhibition	%	8.52
	8091649	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	5.36	CHEMBL3981	Homo sapiens	Inhibition	%	5.36
	8091989	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	8.47	CHEMBL3981	Homo sapiens	Inhibition	%	8.47
	8092126	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	6.38	CHEMBL3981	Homo sapiens	Inhibition	%	6.38
	8092501	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	9.33	CHEMBL3981	Homo sapiens	Inhibition	%	9.33
	8092649	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	4.84	CHEMBL3981	Homo sapiens	Inhibition	%	4.84
	8092873	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.84	CHEMBL3981	Homo sapiens	Inhibition	%	2.84
	8093002	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	79.53	CHEMBL3981	Homo sapiens	Inhibition	%	79.53
	8093314	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	6.36	CHEMBL3981	Homo sapiens	Inhibition	%	6.36
	8093454	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	7.28	CHEMBL3981	Homo sapiens	Inhibition	%	7.28
	8093678	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.81	CHEMBL3981	Homo sapiens	Inhibition	%	-0.81
	8093817	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	10.25	CHEMBL3981	Homo sapiens	Inhibition	%	10.25
	8094161	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	6.5	CHEMBL3981	Homo sapiens	Inhibition	%	6.5
	8094341	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.24	CHEMBL3981	Homo sapiens	Inhibition	%	2.24
	8094740	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.31	CHEMBL3981	Homo sapiens	Inhibition	%	3.31
	8094896	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	7.49	CHEMBL3981	Homo sapiens	Inhibition	%	7.49
	8095260	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	70.36	CHEMBL3981	Homo sapiens	Inhibition	%	70.36
	8095463	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	7.82	CHEMBL3981	Homo sapiens	Inhibition	%	7.82
	8095828	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	14.88	CHEMBL3981	Homo sapiens	Inhibition	%	14.88
	8095976	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.29	CHEMBL3981	Homo sapiens	Inhibition	%	0.29
	8096317	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	9.92	CHEMBL3981	Homo sapiens	Inhibition	%	9.92
	8096456	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	8.33	CHEMBL3981	Homo sapiens	Inhibition	%	8.33
	8096680	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.93	CHEMBL3981	Homo sapiens	Inhibition	%	3.93
	8096836	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	12.89	CHEMBL3981	Homo sapiens	Inhibition	%	12.89
	8097207	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	4.63	CHEMBL3981	Homo sapiens	Inhibition	%	4.63
	8097294	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	59.07	CHEMBL3981	Homo sapiens	Inhibition	%	59.07
	8097514	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	8.12	CHEMBL3981	Homo sapiens	Inhibition	%	8.12
	8097888	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	7.62	CHEMBL3981	Homo sapiens	Inhibition	%	7.62
	8098021	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.65	CHEMBL3981	Homo sapiens	Inhibition	%	0.65
	8098365	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	4.63	CHEMBL3981	Homo sapiens	Inhibition	%	4.63
	8098545	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.3	CHEMBL3981	Homo sapiens	Inhibition	%	2.3
	8098769	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.53	CHEMBL3981	Homo sapiens	Inhibition	%	3.53
	8098954	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	11.84	CHEMBL3981	Homo sapiens	Inhibition	%	11.84
	8099098	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	8.03	CHEMBL3981	Homo sapiens	Inhibition	%	8.03
	8099464	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	10.54	CHEMBL3981	Homo sapiens	Inhibition	%	10.54
	8099658	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.63	CHEMBL3981	Homo sapiens	Inhibition	%	2.63
	8100029	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.12	CHEMBL3981	Homo sapiens	Inhibition	%	5.12
	8100175	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	14.24	CHEMBL3981	Homo sapiens	Inhibition	%	14.24
	8100399	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.55	CHEMBL3981	Homo sapiens	Inhibition	%	2.55
	8100515	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	11.94	CHEMBL3981	Homo sapiens	Inhibition	%	11.94
	8100879	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	12.33	CHEMBL3981	Homo sapiens	Inhibition	%	12.33
	8101039	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.76	CHEMBL3981	Homo sapiens	Inhibition	%	8.76
	8101405	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.37	CHEMBL3981	Homo sapiens	Inhibition	%	1.37
	8101590	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	20.32	CHEMBL3981	Homo sapiens	Inhibition	%	20.32
	8101843	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	8.9	CHEMBL3981	Homo sapiens	Inhibition	%	8.9
	8102222	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.55	CHEMBL3981	Homo sapiens	Inhibition	%	-1.55
	8102353	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	7.1	CHEMBL3981	Homo sapiens	Inhibition	%	7.1
	8102577	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.55	CHEMBL3981	Homo sapiens	Inhibition	%	2.55
	8102697	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	39.38	CHEMBL3981	Homo sapiens	Inhibition	%	39.38
	8103099	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	5.39	CHEMBL3981	Homo sapiens	Inhibition	%	5.39
	8103295	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	7.07	CHEMBL3981	Homo sapiens	Inhibition	%	7.07
	8103433	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	6.21	CHEMBL3981	Homo sapiens	Inhibition	%	6.21
	8103657	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.14	CHEMBL3981	Homo sapiens	Inhibition	%	-0.14
	8103807	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	42.76	CHEMBL3981	Homo sapiens	Inhibition	%	42.76
	8103992	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	4.13	CHEMBL3981	Homo sapiens	Inhibition	%	4.13
	8104216	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	14.11	CHEMBL3981	Homo sapiens	Inhibition	%	14.11
	8104364	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	10.94	CHEMBL3981	Homo sapiens	Inhibition	%	10.94
	8104734	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	8.33	CHEMBL3981	Homo sapiens	Inhibition	%	8.33
	8104848	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.19	CHEMBL3981	Homo sapiens	Inhibition	%	6.19
	8105072	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	8.89	CHEMBL3981	Homo sapiens	Inhibition	%	8.89
	8105212	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.72	CHEMBL3981	Homo sapiens	Inhibition	%	1.72
	8105378	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	12.91	CHEMBL3981	Homo sapiens	Inhibition	%	12.91
	8105602	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	50.13	CHEMBL3981	Homo sapiens	Inhibition	%	50.13
	8105740	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	11.12	CHEMBL3981	Homo sapiens	Inhibition	%	11.12
	8106020	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.85	CHEMBL3981	Homo sapiens	Inhibition	%	2.85
	8106185	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	35.39	CHEMBL3981	Homo sapiens	Inhibition	%	35.39
	8106409	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.34	CHEMBL3981	Homo sapiens	Inhibition	%	2.34
	8106565	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	31.85	CHEMBL3981	Homo sapiens	Inhibition	%	31.85
	8106918	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	8.37	CHEMBL3981	Homo sapiens	Inhibition	%	8.37
	8107039	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.56	CHEMBL3981	Homo sapiens	Inhibition	%	2.56
	8107263	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	7.07	CHEMBL3981	Homo sapiens	Inhibition	%	7.07
	8107435	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	7.36	CHEMBL3981	Homo sapiens	Inhibition	%	7.36
	8107636	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	28.78	CHEMBL3981	Homo sapiens	Inhibition	%	28.78
	8107995	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	12.26	CHEMBL3981	Homo sapiens	Inhibition	%	12.26
	8108153	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	10.44	CHEMBL3981	Homo sapiens	Inhibition	%	10.44
	8108552	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	27.15	CHEMBL3981	Homo sapiens	Inhibition	%	27.15
	8108699	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	63.33	CHEMBL3981	Homo sapiens	Inhibition	%	63.33
	8109065	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.38	CHEMBL3981	Homo sapiens	Inhibition	%	2.38
	8109403	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.07	CHEMBL3981	Homo sapiens	Inhibition	%	5.07
	8109533	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	3.91	CHEMBL3981	Homo sapiens	Inhibition	%	3.91
	8109928	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	81.37	CHEMBL3981	Homo sapiens	Inhibition	%	81.37
	8110060	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	8.54	CHEMBL3981	Homo sapiens	Inhibition	%	8.54
	8110339	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.01	CHEMBL3981	Homo sapiens	Inhibition	%	4.01
	8110729	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	7.46	CHEMBL3981	Homo sapiens	Inhibition	%	7.46
	8110887	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.42	CHEMBL3981	Homo sapiens	Inhibition	%	4.42
	8111234	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	46.79	CHEMBL3981	Homo sapiens	Inhibition	%	46.79
	8111585	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.11	CHEMBL3981	Homo sapiens	Inhibition	%	-0.11
	8111751	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	34.69	CHEMBL3981	Homo sapiens	Inhibition	%	34.69
	8111956	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.16	CHEMBL3981	Homo sapiens	Inhibition	%	3.16
	8112180	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	7.96	CHEMBL3981	Homo sapiens	Inhibition	%	7.96
	8112317	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.54	CHEMBL3981	Homo sapiens	Inhibition	%	0.54
	8112485	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	31.61	CHEMBL3981	Homo sapiens	Inhibition	%	31.61
	8112709	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	8.9	CHEMBL3981	Homo sapiens	Inhibition	%	8.9
	8112881	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.07	CHEMBL3981	Homo sapiens	Inhibition	%	-0.07
	8113033	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	86.9	CHEMBL3981	Homo sapiens	Inhibition	%	86.9
	8113257	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.14	CHEMBL3981	Homo sapiens	Inhibition	%	5.14
	8113393	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.21	CHEMBL3981	Homo sapiens	Inhibition	%	5.21
	8113741	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	6.96	CHEMBL3981	Homo sapiens	Inhibition	%	6.96
	8113857	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.41	CHEMBL3981	Homo sapiens	Inhibition	%	0.41
	8114081	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	3.67	CHEMBL3981	Homo sapiens	Inhibition	%	3.67
	8114257	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	9.88	CHEMBL3981	Homo sapiens	Inhibition	%	9.88
	8114389	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	12.89	CHEMBL3981	Homo sapiens	Inhibition	%	12.89
	8114613	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	9.25	CHEMBL3981	Homo sapiens	Inhibition	%	9.25
	8114665	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	7.27	CHEMBL3981	Homo sapiens	Inhibition	%	7.27
	8114889	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	6.5	CHEMBL3981	Homo sapiens	Inhibition	%	6.5
	8115055	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	24.99	CHEMBL3981	Homo sapiens	Inhibition	%	24.99
	8115220	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	11.31	CHEMBL3981	Homo sapiens	Inhibition	%	11.31
	8115444	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	4.04	CHEMBL3981	Homo sapiens	Inhibition	%	4.04
	8115564	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	57.82	CHEMBL3981	Homo sapiens	Inhibition	%	57.82
	8115921	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	5.64	CHEMBL3981	Homo sapiens	Inhibition	%	5.64
	8116080	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.79	CHEMBL3981	Homo sapiens	Inhibition	%	-1.79
	8116507	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.27	CHEMBL3981	Homo sapiens	Inhibition	%	3.27
	8116641	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.61	CHEMBL3981	Homo sapiens	Inhibition	%	3.61
	8117037	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	24.66	CHEMBL3981	Homo sapiens	Inhibition	%	24.66
	8117208	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.99	CHEMBL3981	Homo sapiens	Inhibition	%	3.99
	8117590	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	8.89	CHEMBL3981	Homo sapiens	Inhibition	%	8.89
	8117720	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.97	CHEMBL3981	Homo sapiens	Inhibition	%	1.97
	8118082	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.63	CHEMBL3981	Homo sapiens	Inhibition	%	4.63
	8118422	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.14	CHEMBL3981	Homo sapiens	Inhibition	%	5.14
	8118594	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	11.66	CHEMBL3981	Homo sapiens	Inhibition	%	11.66
	8118954	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	14.99	CHEMBL3981	Homo sapiens	Inhibition	%	14.99
	8119225	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.47	CHEMBL3981	Homo sapiens	Inhibition	%	2.47
	8119384	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	69.24	CHEMBL3981	Homo sapiens	Inhibition	%	69.24
	8119775	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	14.37	CHEMBL3981	Homo sapiens	Inhibition	%	14.37
	8119894	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.44	CHEMBL3981	Homo sapiens	Inhibition	%	5.44
	8120118	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	27.69	CHEMBL3981	Homo sapiens	Inhibition	%	27.69
	8120257	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.03	CHEMBL3981	Homo sapiens	Inhibition	%	3.03
	8120417	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	4.55	CHEMBL3981	Homo sapiens	Inhibition	%	4.55
	8120641	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.93	CHEMBL3981	Homo sapiens	Inhibition	%	0.93
	8120842	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	11.25	CHEMBL3981	Homo sapiens	Inhibition	%	11.25
	8120970	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.47	CHEMBL3981	Homo sapiens	Inhibition	%	-0.47
	8121194	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.14	CHEMBL3981	Homo sapiens	Inhibition	%	2.14
	8121366	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.08	CHEMBL3981	Homo sapiens	Inhibition	%	3.08
	8121533	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.95	CHEMBL3981	Homo sapiens	Inhibition	%	-0.95
	8121757	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.03	CHEMBL3981	Homo sapiens	Inhibition	%	0.03
	8121920	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	17.36	CHEMBL3981	Homo sapiens	Inhibition	%	17.36
	8122041	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	8.82	CHEMBL3981	Homo sapiens	Inhibition	%	8.82
	8122265	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	20.81	CHEMBL3981	Homo sapiens	Inhibition	%	20.81
	8122403	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	8.33	CHEMBL3981	Homo sapiens	Inhibition	%	8.33
	8122747	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	6.24	CHEMBL3981	Homo sapiens	Inhibition	%	6.24
	8122914	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	8.49	CHEMBL3981	Homo sapiens	Inhibition	%	8.49
	8123138	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	9.09	CHEMBL3981	Homo sapiens	Inhibition	%	9.09
	8123280	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	76.0	CHEMBL3981	Homo sapiens	Inhibition	%	76.0
	8123558	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.17	CHEMBL3981	Homo sapiens	Inhibition	%	3.17
	8123708	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	5.58	CHEMBL3981	Homo sapiens	Inhibition	%	5.58
	8123932	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	26.12	CHEMBL3981	Homo sapiens	Inhibition	%	26.12
	8124099	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	4.49	CHEMBL3981	Homo sapiens	Inhibition	%	4.49
	8124442	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.01	CHEMBL3981	Homo sapiens	Inhibition	%	4.01
	8124581	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	5.81	CHEMBL3981	Homo sapiens	Inhibition	%	5.81
	8124970	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	7.07	CHEMBL3981	Homo sapiens	Inhibition	%	7.07
	8125171	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.86	CHEMBL3981	Homo sapiens	Inhibition	%	4.86
	8125525	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.21	CHEMBL3981	Homo sapiens	Inhibition	%	-0.21
	8125693	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	7.29	CHEMBL3981	Homo sapiens	Inhibition	%	7.29
	8126081	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.44	CHEMBL3981	Homo sapiens	Inhibition	%	-0.44
	8126245	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	60.62	CHEMBL3981	Homo sapiens	Inhibition	%	60.62
	8126584	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	63.06	CHEMBL3981	Homo sapiens	Inhibition	%	63.06
	8126720	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	5.85	CHEMBL3981	Homo sapiens	Inhibition	%	5.85
	8126944	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	16.23	CHEMBL3981	Homo sapiens	Inhibition	%	16.23
	8127066	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.52	CHEMBL3981	Homo sapiens	Inhibition	%	5.52
	8127457	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	12.04	CHEMBL3981	Homo sapiens	Inhibition	%	12.04
	8127599	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	88.3	CHEMBL3981	Homo sapiens	Inhibition	%	88.3
	8127887	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.18	CHEMBL3981	Homo sapiens	Inhibition	%	1.18
	8128263	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.87	CHEMBL3981	Homo sapiens	Inhibition	%	3.87
	8128430	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	16.32	CHEMBL3981	Homo sapiens	Inhibition	%	16.32
	8128773	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	17.45	CHEMBL3981	Homo sapiens	Inhibition	%	17.45
	8128910	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.53	CHEMBL3981	Homo sapiens	Inhibition	%	3.53
	8129134	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	13.62	CHEMBL3981	Homo sapiens	Inhibition	%	13.62
	8129305	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	16.75	CHEMBL3981	Homo sapiens	Inhibition	%	16.75
	8129494	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	8.03	CHEMBL3981	Homo sapiens	Inhibition	%	8.03
	8129857	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.78	CHEMBL3981	Homo sapiens	Inhibition	%	0.78
	8130018	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.56	CHEMBL3981	Homo sapiens	Inhibition	%	2.56
	8130242	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	6.33	CHEMBL3981	Homo sapiens	Inhibition	%	6.33
	8130414	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.07	CHEMBL3981	Homo sapiens	Inhibition	%	-0.07
	8130574	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	7.37	CHEMBL3981	Homo sapiens	Inhibition	%	7.37
	8130914	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	7.57	CHEMBL3981	Homo sapiens	Inhibition	%	7.57
	8131277	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.7	CHEMBL3981	Homo sapiens	Inhibition	%	6.7
	8131397	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	6.96	CHEMBL3981	Homo sapiens	Inhibition	%	6.96
	8131788	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	24.26	CHEMBL3981	Homo sapiens	Inhibition	%	24.26
	8131929	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	26.41	CHEMBL3981	Homo sapiens	Inhibition	%	26.41
	8132153	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	67.86	CHEMBL3981	Homo sapiens	Inhibition	%	67.86
	8132215	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.99	CHEMBL3981	Homo sapiens	Inhibition	%	1.99
	8132586	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	7.88	CHEMBL3981	Homo sapiens	Inhibition	%	7.88
	8132754	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	3.92	CHEMBL3981	Homo sapiens	Inhibition	%	3.92
	8132978	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	8.22	CHEMBL3981	Homo sapiens	Inhibition	%	8.22
	8133099	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.66	CHEMBL3981	Homo sapiens	Inhibition	%	2.66
	8133461	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.88	CHEMBL3981	Homo sapiens	Inhibition	%	3.88
	8133633	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	62.62	CHEMBL3981	Homo sapiens	Inhibition	%	62.62
	8133813	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	26.33	CHEMBL3981	Homo sapiens	Inhibition	%	26.33
	8134037	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	67.67	CHEMBL3981	Homo sapiens	Inhibition	%	67.67
	8134185	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.35	CHEMBL3981	Homo sapiens	Inhibition	%	-1.35
	8134569	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.73	CHEMBL3981	Homo sapiens	Inhibition	%	2.73
	8134753	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.57	CHEMBL3981	Homo sapiens	Inhibition	%	-2.57
	8134913	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	18.02	CHEMBL3981	Homo sapiens	Inhibition	%	18.02
	8135137	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	6.35	CHEMBL3981	Homo sapiens	Inhibition	%	6.35
	8135252	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	8.42	CHEMBL3981	Homo sapiens	Inhibition	%	8.42
	8135617	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	9.79	CHEMBL3981	Homo sapiens	Inhibition	%	9.79
	8135738	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	6.94	CHEMBL3981	Homo sapiens	Inhibition	%	6.94
	8135962	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	7.45	CHEMBL3981	Homo sapiens	Inhibition	%	7.45
	8136130	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.31	CHEMBL3981	Homo sapiens	Inhibition	%	5.31
	8136498	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	8.13	CHEMBL3981	Homo sapiens	Inhibition	%	8.13
	8136564	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.37	CHEMBL3981	Homo sapiens	Inhibition	%	1.37
	8136788	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.05	CHEMBL3981	Homo sapiens	Inhibition	%	2.05
	8136923	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.78	CHEMBL3981	Homo sapiens	Inhibition	%	3.78
	8137310	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	6.3	CHEMBL3981	Homo sapiens	Inhibition	%	6.3
	8137430	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	6.27	CHEMBL3981	Homo sapiens	Inhibition	%	6.27
	8137802	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.08	CHEMBL3981	Homo sapiens	Inhibition	%	4.08
	8137968	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.59	CHEMBL3981	Homo sapiens	Inhibition	%	-0.59
	8138371	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.68	CHEMBL3981	Homo sapiens	Inhibition	%	6.68
	8138519	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.33	CHEMBL3981	Homo sapiens	Inhibition	%	0.33
	8138901	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.18	CHEMBL3981	Homo sapiens	Inhibition	%	5.18
	8139086	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.71	CHEMBL3981	Homo sapiens	Inhibition	%	0.71
	8139469	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	13.72	CHEMBL3981	Homo sapiens	Inhibition	%	13.72
	8139583	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.07	CHEMBL3981	Homo sapiens	Inhibition	%	5.07
	8139807	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	8.24	CHEMBL3981	Homo sapiens	Inhibition	%	8.24
	8139948	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	9.61	CHEMBL3981	Homo sapiens	Inhibition	%	9.61
	8140295	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	6.8	CHEMBL3981	Homo sapiens	Inhibition	%	6.8
	8140454	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.35	CHEMBL3981	Homo sapiens	Inhibition	%	6.35
	8140821	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.17	CHEMBL3981	Homo sapiens	Inhibition	%	7.17
	8141123	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.91	CHEMBL3981	Homo sapiens	Inhibition	%	1.91
	8141253	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	5.17	CHEMBL3981	Homo sapiens	Inhibition	%	5.17
	8141477	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.1	CHEMBL3981	Homo sapiens	Inhibition	%	4.1
	8141637	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	28.42	CHEMBL3981	Homo sapiens	Inhibition	%	28.42
	8141756	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.24	CHEMBL3981	Homo sapiens	Inhibition	%	1.24
	8141980	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	10.35	CHEMBL3981	Homo sapiens	Inhibition	%	10.35
	8142141	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	11.18	CHEMBL3981	Homo sapiens	Inhibition	%	11.18
	8142309	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	4.2	CHEMBL3981	Homo sapiens	Inhibition	%	4.2
	8142533	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	64.55	CHEMBL3981	Homo sapiens	Inhibition	%	64.55
	8142709	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	10.03	CHEMBL3981	Homo sapiens	Inhibition	%	10.03
	8142858	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.21	CHEMBL3981	Homo sapiens	Inhibition	%	-2.21
	8143082	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-5.65	CHEMBL3981	Homo sapiens	Inhibition	%	-5.65
	8143237	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	5.13	CHEMBL3981	Homo sapiens	Inhibition	%	5.13
	8143424	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.81	CHEMBL3981	Homo sapiens	Inhibition	%	4.81
	8143648	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	7.92	CHEMBL3981	Homo sapiens	Inhibition	%	7.92
	8143807	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	8.49	CHEMBL3981	Homo sapiens	Inhibition	%	8.49
	8144145	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	8.55	CHEMBL3981	Homo sapiens	Inhibition	%	8.55
	8144284	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	15.92	CHEMBL3981	Homo sapiens	Inhibition	%	15.92
	8144638	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	8.19	CHEMBL3981	Homo sapiens	Inhibition	%	8.19
	8144791	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.49	CHEMBL3981	Homo sapiens	Inhibition	%	2.49
	8145015	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	4.92	CHEMBL3981	Homo sapiens	Inhibition	%	4.92
	8145152	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	9.92	CHEMBL3981	Homo sapiens	Inhibition	%	9.92
	8145465	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.24	CHEMBL3981	Homo sapiens	Inhibition	%	1.24
	8145813	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	9.62	CHEMBL3981	Homo sapiens	Inhibition	%	9.62
	8145974	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	90.84	CHEMBL3981	Homo sapiens	Inhibition	%	90.84
	8146318	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	18.85	CHEMBL3981	Homo sapiens	Inhibition	%	18.85
	8146478	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	55.08	CHEMBL3981	Homo sapiens	Inhibition	%	55.08
	8146869	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	90.54	CHEMBL3981	Homo sapiens	Inhibition	%	90.54
	8147038	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.0	CHEMBL3981	Homo sapiens	Inhibition	%	3.0
	8147404	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.86	CHEMBL3981	Homo sapiens	Inhibition	%	3.86
	8147557	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	6.55	CHEMBL3981	Homo sapiens	Inhibition	%	6.55
	8147968	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.1	CHEMBL3981	Homo sapiens	Inhibition	%	6.1
	8148126	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	11.53	CHEMBL3981	Homo sapiens	Inhibition	%	11.53
	8148464	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	16.44	CHEMBL3981	Homo sapiens	Inhibition	%	16.44
	8148603	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.31	CHEMBL3981	Homo sapiens	Inhibition	%	5.31
	8148827	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	8.19	CHEMBL3981	Homo sapiens	Inhibition	%	8.19
	8148965	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	7.75	CHEMBL3981	Homo sapiens	Inhibition	%	7.75
	8149348	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.25	CHEMBL3981	Homo sapiens	Inhibition	%	3.25
	8149482	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	17.53	CHEMBL3981	Homo sapiens	Inhibition	%	17.53
	8149804	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	5.93	CHEMBL3981	Homo sapiens	Inhibition	%	5.93
	8150153	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	35.57	CHEMBL3981	Homo sapiens	Inhibition	%	35.57
	8150313	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	86.48	CHEMBL3981	Homo sapiens	Inhibition	%	86.48
	8150657	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	72.7	CHEMBL3981	Homo sapiens	Inhibition	%	72.7
	8150822	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	11.4	CHEMBL3981	Homo sapiens	Inhibition	%	11.4
	8151046	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	17.4	CHEMBL3981	Homo sapiens	Inhibition	%	17.4
	8151209	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.03	CHEMBL3981	Homo sapiens	Inhibition	%	-0.03
	8151386	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	9.07	CHEMBL3981	Homo sapiens	Inhibition	%	9.07
	8151610	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.95	CHEMBL3981	Homo sapiens	Inhibition	%	3.95
	8151748	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	5.68	CHEMBL3981	Homo sapiens	Inhibition	%	5.68
	8151902	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	6.76	CHEMBL3981	Homo sapiens	Inhibition	%	6.76
	8152126	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	12.26	CHEMBL3981	Homo sapiens	Inhibition	%	12.26
	8152314	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	10.6	CHEMBL3981	Homo sapiens	Inhibition	%	10.6
	8152472	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.84	CHEMBL3981	Homo sapiens	Inhibition	%	3.84
	8152696	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	9.44	CHEMBL3981	Homo sapiens	Inhibition	%	9.44
	8152810	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	43.37	CHEMBL3981	Homo sapiens	Inhibition	%	43.37
	8153173	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	17.43	CHEMBL3981	Homo sapiens	Inhibition	%	17.43
	8153310	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	8.82	CHEMBL3981	Homo sapiens	Inhibition	%	8.82
	8153534	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	10.84	CHEMBL3981	Homo sapiens	Inhibition	%	10.84
	8153691	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	7.32	CHEMBL3981	Homo sapiens	Inhibition	%	7.32
	8153824	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	11.82	CHEMBL3981	Homo sapiens	Inhibition	%	11.82
	8154048	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	17.97	CHEMBL3981	Homo sapiens	Inhibition	%	17.97
	8154145	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	16.9	CHEMBL3981	Homo sapiens	Inhibition	%	16.9
	8154369	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.59	CHEMBL3981	Homo sapiens	Inhibition	%	2.59
	8154495	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	76.72	CHEMBL3981	Homo sapiens	Inhibition	%	76.72
	8154654	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.0	CHEMBL3981	Homo sapiens	Inhibition	%	0.0
	8154878	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.51	CHEMBL3981	Homo sapiens	Inhibition	%	4.51
	8154998	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.13	CHEMBL3981	Homo sapiens	Inhibition	%	3.13
	8155398	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.92	CHEMBL3981	Homo sapiens	Inhibition	%	-0.92
	8155559	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.42	CHEMBL3981	Homo sapiens	Inhibition	%	-1.42
	8155961	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	8.22	CHEMBL3981	Homo sapiens	Inhibition	%	8.22
	8156099	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	4.81	CHEMBL3981	Homo sapiens	Inhibition	%	4.81
	8156311	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	11.45	CHEMBL3981	Homo sapiens	Inhibition	%	11.45
	8156535	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.34	CHEMBL3981	Homo sapiens	Inhibition	%	2.34
	8156685	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	9.95	CHEMBL3981	Homo sapiens	Inhibition	%	9.95
	8157052	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	11.66	CHEMBL3981	Homo sapiens	Inhibition	%	11.66
	8157172	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.01	CHEMBL3981	Homo sapiens	Inhibition	%	2.01
	8157396	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.46	CHEMBL3981	Homo sapiens	Inhibition	%	4.46
	8157537	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.36	CHEMBL3981	Homo sapiens	Inhibition	%	6.36
	8157891	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	33.33	CHEMBL3981	Homo sapiens	Inhibition	%	33.33
	8158052	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	7.31	CHEMBL3981	Homo sapiens	Inhibition	%	7.31
	8158302	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	95.26	CHEMBL3981	Homo sapiens	Inhibition	%	95.26
	8158684	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	7.84	CHEMBL3981	Homo sapiens	Inhibition	%	7.84
	8158853	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.84	CHEMBL3981	Homo sapiens	Inhibition	%	4.84
	8159212	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	9.8	CHEMBL3981	Homo sapiens	Inhibition	%	9.8
	8159332	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	7.45	CHEMBL3981	Homo sapiens	Inhibition	%	7.45
	8159556	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.08	CHEMBL3981	Homo sapiens	Inhibition	%	-1.08
	8159687	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	8.5	CHEMBL3981	Homo sapiens	Inhibition	%	8.5
	8160052	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.42	CHEMBL3981	Homo sapiens	Inhibition	%	3.42
	8160189	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.94	CHEMBL3981	Homo sapiens	Inhibition	%	5.94
	8160563	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.75	CHEMBL3981	Homo sapiens	Inhibition	%	-0.75
	8160857	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	15.07	CHEMBL3981	Homo sapiens	Inhibition	%	15.07
	8161007	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	11.91	CHEMBL3981	Homo sapiens	Inhibition	%	11.91
	8161374	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.98	CHEMBL3981	Homo sapiens	Inhibition	%	5.98
	8161723	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	8.75	CHEMBL3981	Homo sapiens	Inhibition	%	8.75
	8161861	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	12.47	CHEMBL3981	Homo sapiens	Inhibition	%	12.47
	8162215	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	73.2	CHEMBL3981	Homo sapiens	Inhibition	%	73.2
	8162375	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	15.91	CHEMBL3981	Homo sapiens	Inhibition	%	15.91
	8162599	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	53.03	CHEMBL3981	Homo sapiens	Inhibition	%	53.03
	8162628	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.37	CHEMBL3981	Homo sapiens	Inhibition	%	4.37
	8162852	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	12.04	CHEMBL3981	Homo sapiens	Inhibition	%	12.04
	8163000	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	6.33	CHEMBL3981	Homo sapiens	Inhibition	%	6.33
	8163169	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	13.11	CHEMBL3981	Homo sapiens	Inhibition	%	13.11
	8163393	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.84	CHEMBL3981	Homo sapiens	Inhibition	%	3.84
	8163527	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	19.03	CHEMBL3981	Homo sapiens	Inhibition	%	19.03
	8163874	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	7.95	CHEMBL3981	Homo sapiens	Inhibition	%	7.95
	8164008	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.27	CHEMBL3981	Homo sapiens	Inhibition	%	7.27
	8164232	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	24.81	CHEMBL3981	Homo sapiens	Inhibition	%	24.81
	8164372	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.32	CHEMBL3981	Homo sapiens	Inhibition	%	1.32
	8164527	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.99	CHEMBL3981	Homo sapiens	Inhibition	%	6.99
	8164751	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	5.05	CHEMBL3981	Homo sapiens	Inhibition	%	5.05
	8164895	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	9.11	CHEMBL3981	Homo sapiens	Inhibition	%	9.11
	8165189	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.25	CHEMBL3981	Homo sapiens	Inhibition	%	7.25
	8165330	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	34.17	CHEMBL3981	Homo sapiens	Inhibition	%	34.17
	8165554	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.78	CHEMBL3981	Homo sapiens	Inhibition	%	4.78
	8165697	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	23.8	CHEMBL3981	Homo sapiens	Inhibition	%	23.8
	8166047	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	49.28	CHEMBL3981	Homo sapiens	Inhibition	%	49.28
	8166185	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.31	CHEMBL3981	Homo sapiens	Inhibition	%	4.31
	8166409	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	16.47	CHEMBL3981	Homo sapiens	Inhibition	%	16.47
	8166539	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.37	CHEMBL3981	Homo sapiens	Inhibition	%	4.37
	8166864	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	77.6	CHEMBL3981	Homo sapiens	Inhibition	%	77.6
	8167176	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.13	CHEMBL3981	Homo sapiens	Inhibition	%	3.13
	8167317	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	26.87	CHEMBL3981	Homo sapiens	Inhibition	%	26.87
	8167705	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.96	CHEMBL3981	Homo sapiens	Inhibition	%	5.96
	8167838	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.56	CHEMBL3981	Homo sapiens	Inhibition	%	9.56
	8168186	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.26	CHEMBL3981	Homo sapiens	Inhibition	%	1.26
	8168551	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.04	CHEMBL3981	Homo sapiens	Inhibition	%	5.04
	8168687	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	6.74	CHEMBL3981	Homo sapiens	Inhibition	%	6.74
	8169075	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	15.76	CHEMBL3981	Homo sapiens	Inhibition	%	15.76
	8169217	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.26	CHEMBL3981	Homo sapiens	Inhibition	%	5.26
	8169521	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.81	CHEMBL3981	Homo sapiens	Inhibition	%	4.81
	8169879	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	19.1	CHEMBL3981	Homo sapiens	Inhibition	%	19.1
	8170024	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	9.76	CHEMBL3981	Homo sapiens	Inhibition	%	9.76
	8170248	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	29.03	CHEMBL3981	Homo sapiens	Inhibition	%	29.03
	8170373	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.27	CHEMBL3981	Homo sapiens	Inhibition	%	3.27
	8170737	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.91	CHEMBL3981	Homo sapiens	Inhibition	%	3.91
	8170872	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	16.6	CHEMBL3981	Homo sapiens	Inhibition	%	16.6
	8171293	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	26.15	CHEMBL3981	Homo sapiens	Inhibition	%	26.15
	8171510	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	9.94	CHEMBL3981	Homo sapiens	Inhibition	%	9.94
	8171651	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.3	CHEMBL3981	Homo sapiens	Inhibition	%	6.3
	8171875	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	17.32	CHEMBL3981	Homo sapiens	Inhibition	%	17.32
	8172028	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.91	CHEMBL3981	Homo sapiens	Inhibition	%	3.91
	8172160	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	13.52	CHEMBL3981	Homo sapiens	Inhibition	%	13.52
	8172384	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	8.73	CHEMBL3981	Homo sapiens	Inhibition	%	8.73
	8172512	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	5.18	CHEMBL3981	Homo sapiens	Inhibition	%	5.18
	8172878	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	12.26	CHEMBL3981	Homo sapiens	Inhibition	%	12.26
	8173014	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.33	CHEMBL3981	Homo sapiens	Inhibition	%	1.33
	8173238	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	7.09	CHEMBL3981	Homo sapiens	Inhibition	%	7.09
	8173403	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	5.83	CHEMBL3981	Homo sapiens	Inhibition	%	5.83
	8173544	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	6.56	CHEMBL3981	Homo sapiens	Inhibition	%	6.56
	8173768	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.55	CHEMBL3981	Homo sapiens	Inhibition	%	3.55
	8173855	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.71	CHEMBL3981	Homo sapiens	Inhibition	%	3.71
	8174079	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	8.99	CHEMBL3981	Homo sapiens	Inhibition	%	8.99
	8174211	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.36	CHEMBL3981	Homo sapiens	Inhibition	%	5.36
	8174583	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.1	CHEMBL3981	Homo sapiens	Inhibition	%	3.1
	8174705	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.33	CHEMBL3981	Homo sapiens	Inhibition	%	4.33
	8175072	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	13.55	CHEMBL3981	Homo sapiens	Inhibition	%	13.55
	8175208	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.13	CHEMBL3981	Homo sapiens	Inhibition	%	3.13
	8175432	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	8.29	CHEMBL3981	Homo sapiens	Inhibition	%	8.29
	8175464	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.16	CHEMBL3981	Homo sapiens	Inhibition	%	4.16
	8175688	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	12.59	CHEMBL3981	Homo sapiens	Inhibition	%	12.59
	8175851	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	13.35	CHEMBL3981	Homo sapiens	Inhibition	%	13.35
	8176228	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.16	CHEMBL3981	Homo sapiens	Inhibition	%	8.16
	8176377	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	11.83	CHEMBL3981	Homo sapiens	Inhibition	%	11.83
	8176733	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	17.0	CHEMBL3981	Homo sapiens	Inhibition	%	17.0
	8176863	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.54	CHEMBL3981	Homo sapiens	Inhibition	%	2.54
	8177087	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.01	CHEMBL3981	Homo sapiens	Inhibition	%	4.01
	8177229	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.3	CHEMBL3981	Homo sapiens	Inhibition	%	5.3
	8177591	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	9.72	CHEMBL3981	Homo sapiens	Inhibition	%	9.72
	8177755	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	33.51	CHEMBL3981	Homo sapiens	Inhibition	%	33.51
	8178119	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.51	CHEMBL3981	Homo sapiens	Inhibition	%	3.51
	8178431	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.18	CHEMBL3981	Homo sapiens	Inhibition	%	4.18
	8178558	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	26.23	CHEMBL3981	Homo sapiens	Inhibition	%	26.23
	8178931	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.77	CHEMBL3981	Homo sapiens	Inhibition	%	-0.77
	8179054	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.53	CHEMBL3981	Homo sapiens	Inhibition	%	3.53
	8179278	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	9.99	CHEMBL3981	Homo sapiens	Inhibition	%	9.99
	8179422	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.56	CHEMBL3981	Homo sapiens	Inhibition	%	4.56
	8179783	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.22	CHEMBL3981	Homo sapiens	Inhibition	%	2.22
	8180040	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	8.49	CHEMBL3981	Homo sapiens	Inhibition	%	8.49
	8180194	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	51.41	CHEMBL3981	Homo sapiens	Inhibition	%	51.41
	8180574	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	24.21	CHEMBL3981	Homo sapiens	Inhibition	%	24.21
	8180722	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.0	CHEMBL3981	Homo sapiens	Inhibition	%	3.0
	8180946	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	18.11	CHEMBL3981	Homo sapiens	Inhibition	%	18.11
	8181079	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	8.9	CHEMBL3981	Homo sapiens	Inhibition	%	8.9
	8181434	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.97	CHEMBL3981	Homo sapiens	Inhibition	%	0.97
	8181574	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	39.73	CHEMBL3981	Homo sapiens	Inhibition	%	39.73
	8181937	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	40.25	CHEMBL3981	Homo sapiens	Inhibition	%	40.25
	8182100	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.75	CHEMBL3981	Homo sapiens	Inhibition	%	5.75
	8182324	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	10.07	CHEMBL3981	Homo sapiens	Inhibition	%	10.07
	8182464	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.37	CHEMBL3981	Homo sapiens	Inhibition	%	3.37
	8182780	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	8.61	CHEMBL3981	Homo sapiens	Inhibition	%	8.61
	8182902	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.75	CHEMBL3981	Homo sapiens	Inhibition	%	6.75
	8183126	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	10.94	CHEMBL3981	Homo sapiens	Inhibition	%	10.94
	8183275	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.31	CHEMBL3981	Homo sapiens	Inhibition	%	4.31
	8183628	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	10.46	CHEMBL3981	Homo sapiens	Inhibition	%	10.46
	8183770	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	9.47	CHEMBL3981	Homo sapiens	Inhibition	%	9.47
	8184130	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.54	CHEMBL3981	Homo sapiens	Inhibition	%	5.54
	8184396	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	9.99	CHEMBL3981	Homo sapiens	Inhibition	%	9.99
	8184543	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.11	CHEMBL3981	Homo sapiens	Inhibition	%	2.11
	8184767	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	11.88	CHEMBL3981	Homo sapiens	Inhibition	%	11.88
	8184924	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	10.83	CHEMBL3981	Homo sapiens	Inhibition	%	10.83
	8185297	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.67	CHEMBL3981	Homo sapiens	Inhibition	%	0.67
	8185428	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	36.74	CHEMBL3981	Homo sapiens	Inhibition	%	36.74
	8185783	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	9.28	CHEMBL3981	Homo sapiens	Inhibition	%	9.28
	8185922	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.04	CHEMBL3981	Homo sapiens	Inhibition	%	4.04
	8186146	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	19.94	CHEMBL3981	Homo sapiens	Inhibition	%	19.94
	8186287	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.15	CHEMBL3981	Homo sapiens	Inhibition	%	7.15
	8186675	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.19	CHEMBL3981	Homo sapiens	Inhibition	%	4.19
	8186814	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.68	CHEMBL3981	Homo sapiens	Inhibition	%	0.68
	8187136	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.97	CHEMBL3981	Homo sapiens	Inhibition	%	4.97
	8187484	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.75	CHEMBL3981	Homo sapiens	Inhibition	%	4.75
	8187632	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	8.64	CHEMBL3981	Homo sapiens	Inhibition	%	8.64
	8187985	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	30.12	CHEMBL3981	Homo sapiens	Inhibition	%	30.12
	8188128	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	6.82	CHEMBL3981	Homo sapiens	Inhibition	%	6.82
	8188352	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	6.74	CHEMBL3981	Homo sapiens	Inhibition	%	6.74
	8188487	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	6.63	CHEMBL3981	Homo sapiens	Inhibition	%	6.63
	8188761	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	22.07	CHEMBL3981	Homo sapiens	Inhibition	%	22.07
	8189133	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.0	CHEMBL3981	Homo sapiens	Inhibition	%	3.0
	8189289	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	41.83	CHEMBL3981	Homo sapiens	Inhibition	%	41.83
	8189662	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	8.18	CHEMBL3981	Homo sapiens	Inhibition	%	8.18
	8189794	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	23.41	CHEMBL3981	Homo sapiens	Inhibition	%	23.41
	8190018	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	75.42	CHEMBL3981	Homo sapiens	Inhibition	%	75.42
	8190150	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.49	CHEMBL3981	Homo sapiens	Inhibition	%	5.49
	8190514	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.67	CHEMBL3981	Homo sapiens	Inhibition	%	6.67
	8190651	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	23.51	CHEMBL3981	Homo sapiens	Inhibition	%	23.51
	8190875	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.56	CHEMBL3981	Homo sapiens	Inhibition	%	4.56
	8191039	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	10.45	CHEMBL3981	Homo sapiens	Inhibition	%	10.45
	8191177	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	7.91	CHEMBL3981	Homo sapiens	Inhibition	%	7.91
	8191401	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	36.7	CHEMBL3981	Homo sapiens	Inhibition	%	36.7
	8191497	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	20.24	CHEMBL3981	Homo sapiens	Inhibition	%	20.24
	8191843	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	10.64	CHEMBL3981	Homo sapiens	Inhibition	%	10.64
	8191992	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.38	CHEMBL3981	Homo sapiens	Inhibition	%	1.38
	8192216	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.08	CHEMBL3981	Homo sapiens	Inhibition	%	5.08
	8192345	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	13.25	CHEMBL3981	Homo sapiens	Inhibition	%	13.25
	8192713	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.73	CHEMBL3981	Homo sapiens	Inhibition	%	6.73
	8192849	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	16.3	CHEMBL3981	Homo sapiens	Inhibition	%	16.3
	8193073	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.06	CHEMBL3981	Homo sapiens	Inhibition	%	-0.06
	8193121	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	66.95	CHEMBL3981	Homo sapiens	Inhibition	%	66.95
	8193345	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	6.15	CHEMBL3981	Homo sapiens	Inhibition	%	6.15
	8193490	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	21.72	CHEMBL3981	Homo sapiens	Inhibition	%	21.72
	8193647	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.31	CHEMBL3981	Homo sapiens	Inhibition	%	4.31
	8193871	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	9.72	CHEMBL3981	Homo sapiens	Inhibition	%	9.72
	8194020	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.24	CHEMBL3981	Homo sapiens	Inhibition	%	-0.24
	8194375	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	21.05	CHEMBL3981	Homo sapiens	Inhibition	%	21.05
	8194506	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.99	CHEMBL3981	Homo sapiens	Inhibition	%	5.99
	8194730	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	7.48	CHEMBL3981	Homo sapiens	Inhibition	%	7.48
	8194873	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	9.99	CHEMBL3981	Homo sapiens	Inhibition	%	9.99
	8195230	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	8.57	CHEMBL3981	Homo sapiens	Inhibition	%	8.57
	8195394	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.59	CHEMBL3981	Homo sapiens	Inhibition	%	4.59
	8195757	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.01	CHEMBL3981	Homo sapiens	Inhibition	%	6.01
	8195855	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.31	CHEMBL3981	Homo sapiens	Inhibition	%	0.31
	8196079	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.22	CHEMBL3981	Homo sapiens	Inhibition	%	2.22
	8196196	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.04	CHEMBL3981	Homo sapiens	Inhibition	%	4.04
	8196570	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	7.71	CHEMBL3981	Homo sapiens	Inhibition	%	7.71
	8196698	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	20.67	CHEMBL3981	Homo sapiens	Inhibition	%	20.67
	8196922	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	75.93	CHEMBL3981	Homo sapiens	Inhibition	%	75.93
	8197063	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	9.43	CHEMBL3981	Homo sapiens	Inhibition	%	9.43
	8197424	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	3.44	CHEMBL3981	Homo sapiens	Inhibition	%	3.44
	8197699	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.86	CHEMBL3981	Homo sapiens	Inhibition	%	5.86
	8197839	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	67.28	CHEMBL3981	Homo sapiens	Inhibition	%	67.28
	8198220	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.88	CHEMBL3981	Homo sapiens	Inhibition	%	1.88
	8198358	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.42	CHEMBL3981	Homo sapiens	Inhibition	%	2.42
	8198712	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	70.08	CHEMBL3981	Homo sapiens	Inhibition	%	70.08
	8199067	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.68	CHEMBL3981	Homo sapiens	Inhibition	%	8.68
	8199215	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.78	CHEMBL3981	Homo sapiens	Inhibition	%	6.78
	8199573	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.78	CHEMBL3981	Homo sapiens	Inhibition	%	2.78
	8199736	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	15.05	CHEMBL3981	Homo sapiens	Inhibition	%	15.05
	8200098	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.97	CHEMBL3981	Homo sapiens	Inhibition	%	4.97
	8200426	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.2	CHEMBL3981	Homo sapiens	Inhibition	%	4.2
	8200541	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	8.14	CHEMBL3981	Homo sapiens	Inhibition	%	8.14
	8200765	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.88	CHEMBL3981	Homo sapiens	Inhibition	%	5.88
	8200915	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	22.81	CHEMBL3981	Homo sapiens	Inhibition	%	22.81
	8201269	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	93.52	CHEMBL3981	Homo sapiens	Inhibition	%	93.52
	8201404	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.53	CHEMBL3981	Homo sapiens	Inhibition	%	3.53
	8201761	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	52.38	CHEMBL3981	Homo sapiens	Inhibition	%	52.38
	8202040	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.11	CHEMBL3981	Homo sapiens	Inhibition	%	3.11
	8202180	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	99.0	CHEMBL3981	Homo sapiens	Inhibition	%	99.0
	8202404	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.74	CHEMBL3981	Homo sapiens	Inhibition	%	2.74
	8202571	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	6.87	CHEMBL3981	Homo sapiens	Inhibition	%	6.87
	8202696	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.15	CHEMBL3981	Homo sapiens	Inhibition	%	6.15
	8202920	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	11.15	CHEMBL3981	Homo sapiens	Inhibition	%	11.15
	8203050	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.59	CHEMBL3981	Homo sapiens	Inhibition	%	7.59
	8203405	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	23.41	CHEMBL3981	Homo sapiens	Inhibition	%	23.41
	8203551	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	14.36	CHEMBL3981	Homo sapiens	Inhibition	%	14.36
	8203775	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.84	CHEMBL3981	Homo sapiens	Inhibition	%	4.84
	8203909	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	11.73	CHEMBL3981	Homo sapiens	Inhibition	%	11.73
	8204075	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.45	CHEMBL3981	Homo sapiens	Inhibition	%	5.45
	8204299	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	17.51	CHEMBL3981	Homo sapiens	Inhibition	%	17.51
	8204436	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	11.06	CHEMBL3981	Homo sapiens	Inhibition	%	11.06
	8204765	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	40.76	CHEMBL3981	Homo sapiens	Inhibition	%	40.76
	8205104	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	19.47	CHEMBL3981	Homo sapiens	Inhibition	%	19.47
	8205253	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.74	CHEMBL3981	Homo sapiens	Inhibition	%	5.74
	8205613	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	11.46	CHEMBL3981	Homo sapiens	Inhibition	%	11.46
	8205752	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	9.35	CHEMBL3981	Homo sapiens	Inhibition	%	9.35
	8205976	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.11	CHEMBL3981	Homo sapiens	Inhibition	%	3.11
	8206108	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	97.29	CHEMBL3981	Homo sapiens	Inhibition	%	97.29
	8206384	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	7.45	CHEMBL3981	Homo sapiens	Inhibition	%	7.45
	8206751	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	6.29	CHEMBL3981	Homo sapiens	Inhibition	%	6.29
	8206931	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.09	CHEMBL3981	Homo sapiens	Inhibition	%	3.09
	8207281	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	8.2	CHEMBL3981	Homo sapiens	Inhibition	%	8.2
	8207411	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	32.42	CHEMBL3981	Homo sapiens	Inhibition	%	32.42
	8207635	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	16.21	CHEMBL3981	Homo sapiens	Inhibition	%	16.21
	8207767	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	64.39	CHEMBL3981	Homo sapiens	Inhibition	%	64.39
	8208136	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.98	CHEMBL3981	Homo sapiens	Inhibition	%	1.98
	8208268	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.75	CHEMBL3981	Homo sapiens	Inhibition	%	5.75
	8208658	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.65	CHEMBL3981	Homo sapiens	Inhibition	%	2.65
	8208791	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	47.65	CHEMBL3981	Homo sapiens	Inhibition	%	47.65
	8209015	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.02	CHEMBL3981	Homo sapiens	Inhibition	%	7.02
	8209120	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.05	CHEMBL3981	Homo sapiens	Inhibition	%	2.05
	8209460	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.91	CHEMBL3981	Homo sapiens	Inhibition	%	2.91
	8209610	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	12.13	CHEMBL3981	Homo sapiens	Inhibition	%	12.13
	8209834	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.04	CHEMBL3981	Homo sapiens	Inhibition	%	4.04
	8209970	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	19.89	CHEMBL3981	Homo sapiens	Inhibition	%	19.89
	8210335	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	8.8	CHEMBL3981	Homo sapiens	Inhibition	%	8.8
	8210471	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.57	CHEMBL3981	Homo sapiens	Inhibition	%	-1.57
	8210730	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.71	CHEMBL3981	Homo sapiens	Inhibition	%	2.71
	8211098	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.81	CHEMBL3981	Homo sapiens	Inhibition	%	6.81
	8211268	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.11	CHEMBL3981	Homo sapiens	Inhibition	%	6.11
	8211615	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	14.37	CHEMBL3981	Homo sapiens	Inhibition	%	14.37
	8211968	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	61.34	CHEMBL3981	Homo sapiens	Inhibition	%	61.34
	8212100	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	8.31	CHEMBL3981	Homo sapiens	Inhibition	%	8.31
	8212465	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.84	CHEMBL3981	Homo sapiens	Inhibition	%	3.84
	8212598	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	8.57	CHEMBL3981	Homo sapiens	Inhibition	%	8.57
	8212822	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.23	CHEMBL3981	Homo sapiens	Inhibition	%	6.23
	8212992	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.84	CHEMBL3981	Homo sapiens	Inhibition	%	2.84
	8213345	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	15.05	CHEMBL3981	Homo sapiens	Inhibition	%	15.05
	8213449	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	15.39	CHEMBL3981	Homo sapiens	Inhibition	%	15.39
	8213673	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.94	CHEMBL3981	Homo sapiens	Inhibition	%	-1.94
	8213786	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.82	CHEMBL3981	Homo sapiens	Inhibition	%	5.82
	8214157	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.59	CHEMBL3981	Homo sapiens	Inhibition	%	5.59
	8214294	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	99.32	CHEMBL3981	Homo sapiens	Inhibition	%	99.32
	8214652	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	7.05	CHEMBL3981	Homo sapiens	Inhibition	%	7.05
	8214804	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.93	CHEMBL3981	Homo sapiens	Inhibition	%	1.93
	8215028	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.53	CHEMBL3981	Homo sapiens	Inhibition	%	3.53
	8215055	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.75	CHEMBL3981	Homo sapiens	Inhibition	%	6.75
	8215279	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.38	CHEMBL3981	Homo sapiens	Inhibition	%	3.38
	8215432	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	21.64	CHEMBL3981	Homo sapiens	Inhibition	%	21.64
	8215596	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	8.09	CHEMBL3981	Homo sapiens	Inhibition	%	8.09
	8215820	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	7.76	CHEMBL3981	Homo sapiens	Inhibition	%	7.76
	8215939	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.3	CHEMBL3981	Homo sapiens	Inhibition	%	6.3
	8216282	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	9.21	CHEMBL3981	Homo sapiens	Inhibition	%	9.21
	8216418	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	10.75	CHEMBL3981	Homo sapiens	Inhibition	%	10.75
	8216642	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	6.67	CHEMBL3981	Homo sapiens	Inhibition	%	6.67
	8216780	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	8.91	CHEMBL3981	Homo sapiens	Inhibition	%	8.91
	8217138	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.39	CHEMBL3981	Homo sapiens	Inhibition	%	7.39
	8217312	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.49	CHEMBL3981	Homo sapiens	Inhibition	%	0.49
	8217667	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	35.54	CHEMBL3981	Homo sapiens	Inhibition	%	35.54
	8217992	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.03	CHEMBL3981	Homo sapiens	Inhibition	%	-1.03
	8218107	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	22.15	CHEMBL3981	Homo sapiens	Inhibition	%	22.15
	8218458	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	23.01	CHEMBL3981	Homo sapiens	Inhibition	%	23.01
	8218601	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	88.05	CHEMBL3981	Homo sapiens	Inhibition	%	88.05
	8218825	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	49.45	CHEMBL3981	Homo sapiens	Inhibition	%	49.45
	8218956	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	38.93	CHEMBL3981	Homo sapiens	Inhibition	%	38.93
	8219340	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	6.24	CHEMBL3981	Homo sapiens	Inhibition	%	6.24
	8219590	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	7.74	CHEMBL3981	Homo sapiens	Inhibition	%	7.74
	8219751	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.11	CHEMBL3981	Homo sapiens	Inhibition	%	3.11
	8220144	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.67	CHEMBL3981	Homo sapiens	Inhibition	%	5.67
	8220273	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	9.7	CHEMBL3981	Homo sapiens	Inhibition	%	9.7
	8220497	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	8.1	CHEMBL3981	Homo sapiens	Inhibition	%	8.1
	8220611	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	25.97	CHEMBL3981	Homo sapiens	Inhibition	%	25.97
	8220973	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	16.05	CHEMBL3981	Homo sapiens	Inhibition	%	16.05
	8221109	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.14	CHEMBL3981	Homo sapiens	Inhibition	%	3.14
	8221333	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	14.12	CHEMBL3981	Homo sapiens	Inhibition	%	14.12
	8221466	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.69	CHEMBL3981	Homo sapiens	Inhibition	%	5.69
	8221631	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.71	CHEMBL3981	Homo sapiens	Inhibition	%	2.71
	8221855	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.07	CHEMBL3981	Homo sapiens	Inhibition	%	0.07
	8221986	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	71.65	CHEMBL3981	Homo sapiens	Inhibition	%	71.65
	8222308	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	6.16	CHEMBL3981	Homo sapiens	Inhibition	%	6.16
	8222442	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	69.17	CHEMBL3981	Homo sapiens	Inhibition	%	69.17
	8222666	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	5.53	CHEMBL3981	Homo sapiens	Inhibition	%	5.53
	8222784	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	61.25	CHEMBL3981	Homo sapiens	Inhibition	%	61.25
	8223152	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	91.31	CHEMBL3981	Homo sapiens	Inhibition	%	91.31
	8223281	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	12.79	CHEMBL3981	Homo sapiens	Inhibition	%	12.79
	8223505	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	50.16	CHEMBL3981	Homo sapiens	Inhibition	%	50.16
	8223666	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	5.28	CHEMBL3981	Homo sapiens	Inhibition	%	5.28
	8223916	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	43.93	CHEMBL3981	Homo sapiens	Inhibition	%	43.93
	8224078	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	8.06	CHEMBL3981	Homo sapiens	Inhibition	%	8.06
	8224302	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.49	CHEMBL3981	Homo sapiens	Inhibition	%	3.49
	8224472	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.89	CHEMBL3981	Homo sapiens	Inhibition	%	6.89
	8224831	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	12.04	CHEMBL3981	Homo sapiens	Inhibition	%	12.04
	8224945	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	6.25	CHEMBL3981	Homo sapiens	Inhibition	%	6.25
	8225303	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.23	CHEMBL3981	Homo sapiens	Inhibition	%	6.23
	8225665	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.05	CHEMBL3981	Homo sapiens	Inhibition	%	-0.05
	8225800	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	9.11	CHEMBL3981	Homo sapiens	Inhibition	%	9.11
	8226182	CHEMBL1962201	GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.32	CHEMBL3981	Homo sapiens	Inhibition	%	-0.32
	8226307	CHEMBL1962200	GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.76	CHEMBL3981	Homo sapiens	Inhibition	%	5.76
	10838719	CHEMBL2014945	Inhibition of LOK at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	20.0	CHEMBL3981	Homo sapiens	INH	%	20.0
	10926098	CHEMBL2046128	Inhibition of human LOK assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	102.0	CHEMBL3981	Homo sapiens	Activity	%	102.0
	10926099	CHEMBL2046128	Inhibition of human LOK assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	94.0	CHEMBL3981	Homo sapiens	Activity	%	94.0
	12172378	CHEMBL2210643	Inhibition of LOK assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3981	Homo sapiens	Activity	%	100.0
	12223521	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	100.0	CHEMBL3981	Homo sapiens	Residual Activity	%	100.0
	12223522	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	39.0	CHEMBL3981	Homo sapiens	Residual Activity	%	39.0
	12223523	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12223524	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12223525	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	27.0	CHEMBL3981	Homo sapiens	Residual Activity	%	27.0
	12223526	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	98.0	CHEMBL3981	Homo sapiens	Residual Activity	%	98.0
	12223527	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	45.0	CHEMBL3981	Homo sapiens	Residual Activity	%	45.0
	12223528	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	24.0	CHEMBL3981	Homo sapiens	Residual Activity	%	24.0
	12223529	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	107.0	CHEMBL3981	Homo sapiens	Residual Activity	%	107.0
	12223530	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	31.0	CHEMBL3981	Homo sapiens	Residual Activity	%	31.0
	12223531	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12223532	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12223533	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	50.0	CHEMBL3981	Homo sapiens	Residual Activity	%	50.0
	12223534	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	80.0	CHEMBL3981	Homo sapiens	Residual Activity	%	80.0
	12223535	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	84.0	CHEMBL3981	Homo sapiens	Residual Activity	%	84.0
	12223536	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	94.0	CHEMBL3981	Homo sapiens	Residual Activity	%	94.0
	12223537	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	107.0	CHEMBL3981	Homo sapiens	Residual Activity	%	107.0
	12223538	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	100.0	CHEMBL3981	Homo sapiens	Residual Activity	%	100.0
	12223539	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	100.0	CHEMBL3981	Homo sapiens	Residual Activity	%	100.0
	12223540	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	72.0	CHEMBL3981	Homo sapiens	Residual Activity	%	72.0
	12223541	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	85.0	CHEMBL3981	Homo sapiens	Residual Activity	%	85.0
	12223542	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	89.0	CHEMBL3981	Homo sapiens	Residual Activity	%	89.0
	12223543	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	104.0	CHEMBL3981	Homo sapiens	Residual Activity	%	104.0
	12223544	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	82.0	CHEMBL3981	Homo sapiens	Residual Activity	%	82.0
	12223545	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	111.0	CHEMBL3981	Homo sapiens	Residual Activity	%	111.0
	12223546	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	23.0	CHEMBL3981	Homo sapiens	Residual Activity	%	23.0
	12223547	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	55.0	CHEMBL3981	Homo sapiens	Residual Activity	%	55.0
	12223548	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	17.0	CHEMBL3981	Homo sapiens	Residual Activity	%	17.0
	12223549	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12223550	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	21.0	CHEMBL3981	Homo sapiens	Residual Activity	%	21.0
	12223551	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12223552	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	8.0	CHEMBL3981	Homo sapiens	Residual Activity	%	8.0
	12223553	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	109.0	CHEMBL3981	Homo sapiens	Residual Activity	%	109.0
	12223554	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	98.0	CHEMBL3981	Homo sapiens	Residual Activity	%	98.0
	12223555	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	88.0	CHEMBL3981	Homo sapiens	Residual Activity	%	88.0
	12223556	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	87.0	CHEMBL3981	Homo sapiens	Residual Activity	%	87.0
	12223557	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	59.0	CHEMBL3981	Homo sapiens	Residual Activity	%	59.0
	12223558	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	85.0	CHEMBL3981	Homo sapiens	Residual Activity	%	85.0
	12223559	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	87.0	CHEMBL3981	Homo sapiens	Residual Activity	%	87.0
	12223560	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	74.0	CHEMBL3981	Homo sapiens	Residual Activity	%	74.0
	12223561	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	110.0	CHEMBL3981	Homo sapiens	Residual Activity	%	110.0
	12223562	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL3981	Homo sapiens	Residual Activity	%	102.0
	12223563	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	21.0	CHEMBL3981	Homo sapiens	Residual Activity	%	21.0
	12223564	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	8.0	CHEMBL3981	Homo sapiens	Residual Activity	%	8.0
	12223565	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	6.0	CHEMBL3981	Homo sapiens	Residual Activity	%	6.0
	12223566	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	86.0	CHEMBL3981	Homo sapiens	Residual Activity	%	86.0
	12223567	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	101.0	CHEMBL3981	Homo sapiens	Residual Activity	%	101.0
	12223568	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	86.0	CHEMBL3981	Homo sapiens	Residual Activity	%	86.0
	12223569	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	98.0	CHEMBL3981	Homo sapiens	Residual Activity	%	98.0
	12223570	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12223571	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	54.0	CHEMBL3981	Homo sapiens	Residual Activity	%	54.0
	12223572	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	73.0	CHEMBL3981	Homo sapiens	Residual Activity	%	73.0
	12223573	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	29.0	CHEMBL3981	Homo sapiens	Residual Activity	%	29.0
	12223574	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	54.0	CHEMBL3981	Homo sapiens	Residual Activity	%	54.0
	12223575	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	94.0	CHEMBL3981	Homo sapiens	Residual Activity	%	94.0
	12223576	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	110.0	CHEMBL3981	Homo sapiens	Residual Activity	%	110.0
	12223577	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	71.0	CHEMBL3981	Homo sapiens	Residual Activity	%	71.0
	12223578	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	107.0	CHEMBL3981	Homo sapiens	Residual Activity	%	107.0
	12223579	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12223580	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	89.0	CHEMBL3981	Homo sapiens	Residual Activity	%	89.0
	12223581	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	67.0	CHEMBL3981	Homo sapiens	Residual Activity	%	67.0
	12223582	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	21.0	CHEMBL3981	Homo sapiens	Residual Activity	%	21.0
	12223583	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	98.0	CHEMBL3981	Homo sapiens	Residual Activity	%	98.0
	12223584	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	91.0	CHEMBL3981	Homo sapiens	Residual Activity	%	91.0
	12223585	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	123.0	CHEMBL3981	Homo sapiens	Residual Activity	%	123.0
	12223586	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	100.0	CHEMBL3981	Homo sapiens	Residual Activity	%	100.0
	12223587	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	100.0	CHEMBL3981	Homo sapiens	Residual Activity	%	100.0
	12223588	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	95.0	CHEMBL3981	Homo sapiens	Residual Activity	%	95.0
	12223589	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	71.0	CHEMBL3981	Homo sapiens	Residual Activity	%	71.0
	12223590	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	67.0	CHEMBL3981	Homo sapiens	Residual Activity	%	67.0
	12223591	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	89.0	CHEMBL3981	Homo sapiens	Residual Activity	%	89.0
	12223592	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	66.0	CHEMBL3981	Homo sapiens	Residual Activity	%	66.0
	12223593	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	33.0	CHEMBL3981	Homo sapiens	Residual Activity	%	33.0
	12223594	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	51.0	CHEMBL3981	Homo sapiens	Residual Activity	%	51.0
	12223595	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	75.0	CHEMBL3981	Homo sapiens	Residual Activity	%	75.0
	12223596	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	13.0	CHEMBL3981	Homo sapiens	Residual Activity	%	13.0
	12223597	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	89.0	CHEMBL3981	Homo sapiens	Residual Activity	%	89.0
	12223598	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	15.0	CHEMBL3981	Homo sapiens	Residual Activity	%	15.0
	12223599	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12223600	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3981	Homo sapiens	Residual Activity	%	0.0
	12223601	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	111.0	CHEMBL3981	Homo sapiens	Residual Activity	%	111.0
	12223602	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	17.0	CHEMBL3981	Homo sapiens	Residual Activity	%	17.0
	12223603	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	98.0	CHEMBL3981	Homo sapiens	Residual Activity	%	98.0
	12223604	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12223605	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	63.0	CHEMBL3981	Homo sapiens	Residual Activity	%	63.0
	12223606	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	112.0	CHEMBL3981	Homo sapiens	Residual Activity	%	112.0
	12223607	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	108.0	CHEMBL3981	Homo sapiens	Residual Activity	%	108.0
	12223608	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	109.0	CHEMBL3981	Homo sapiens	Residual Activity	%	109.0
	12223609	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	98.0	CHEMBL3981	Homo sapiens	Residual Activity	%	98.0
	12223610	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	66.0	CHEMBL3981	Homo sapiens	Residual Activity	%	66.0
	12223611	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	94.0	CHEMBL3981	Homo sapiens	Residual Activity	%	94.0
	12223612	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	80.0	CHEMBL3981	Homo sapiens	Residual Activity	%	80.0
	12223613	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	50.0	CHEMBL3981	Homo sapiens	Residual Activity	%	50.0
	12223614	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	112.0	CHEMBL3981	Homo sapiens	Residual Activity	%	112.0
	12223615	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	110.0	CHEMBL3981	Homo sapiens	Residual Activity	%	110.0
	12223616	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL3981	Homo sapiens	Residual Activity	%	106.0
	12223617	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	112.0	CHEMBL3981	Homo sapiens	Residual Activity	%	112.0
	12223618	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	109.0	CHEMBL3981	Homo sapiens	Residual Activity	%	109.0
	12223619	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	113.0	CHEMBL3981	Homo sapiens	Residual Activity	%	113.0
	12223620	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	100.0	CHEMBL3981	Homo sapiens	Residual Activity	%	100.0
	12223621	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	70.0	CHEMBL3981	Homo sapiens	Residual Activity	%	70.0
	12223622	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL3981	Homo sapiens	Residual Activity	%	3.0
	12223623	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	114.0	CHEMBL3981	Homo sapiens	Residual Activity	%	114.0
	12223624	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	116.0	CHEMBL3981	Homo sapiens	Residual Activity	%	116.0
	12223625	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	102.0	CHEMBL3981	Homo sapiens	Residual Activity	%	102.0
	12223626	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	102.0	CHEMBL3981	Homo sapiens	Residual Activity	%	102.0
	12223627	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	99.0	CHEMBL3981	Homo sapiens	Residual Activity	%	99.0
	12223628	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	94.0	CHEMBL3981	Homo sapiens	Residual Activity	%	94.0
	12223629	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	102.0	CHEMBL3981	Homo sapiens	Residual Activity	%	102.0
	12223630	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12223631	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	114.0	CHEMBL3981	Homo sapiens	Residual Activity	%	114.0
	12223632	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	119.0	CHEMBL3981	Homo sapiens	Residual Activity	%	119.0
	12223633	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	57.0	CHEMBL3981	Homo sapiens	Residual Activity	%	57.0
	12223634	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	84.0	CHEMBL3981	Homo sapiens	Residual Activity	%	84.0
	12223635	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	83.0	CHEMBL3981	Homo sapiens	Residual Activity	%	83.0
	12223636	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	95.0	CHEMBL3981	Homo sapiens	Residual Activity	%	95.0
	12223637	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	51.0	CHEMBL3981	Homo sapiens	Residual Activity	%	51.0
	12223638	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	107.0	CHEMBL3981	Homo sapiens	Residual Activity	%	107.0
	12223639	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	99.0	CHEMBL3981	Homo sapiens	Residual Activity	%	99.0
	12223640	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	121.0	CHEMBL3981	Homo sapiens	Residual Activity	%	121.0
	12223641	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	80.0	CHEMBL3981	Homo sapiens	Residual Activity	%	80.0
	12223642	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	60.0	CHEMBL3981	Homo sapiens	Residual Activity	%	60.0
	12223643	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	89.0	CHEMBL3981	Homo sapiens	Residual Activity	%	89.0
	12223644	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	104.0	CHEMBL3981	Homo sapiens	Residual Activity	%	104.0
	12223645	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	62.0	CHEMBL3981	Homo sapiens	Residual Activity	%	62.0
	12223646	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	109.0	CHEMBL3981	Homo sapiens	Residual Activity	%	109.0
	12223647	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	91.0	CHEMBL3981	Homo sapiens	Residual Activity	%	91.0
	12223648	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	109.0	CHEMBL3981	Homo sapiens	Residual Activity	%	109.0
	12223649	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12223650	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL3981	Homo sapiens	Residual Activity	%	0.0
	12223651	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	101.0	CHEMBL3981	Homo sapiens	Residual Activity	%	101.0
	12223652	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	115.0	CHEMBL3981	Homo sapiens	Residual Activity	%	115.0
	12223653	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	87.0	CHEMBL3981	Homo sapiens	Residual Activity	%	87.0
	12223654	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	95.0	CHEMBL3981	Homo sapiens	Residual Activity	%	95.0
	12223655	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	34.0	CHEMBL3981	Homo sapiens	Residual Activity	%	34.0
	12223656	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	57.0	CHEMBL3981	Homo sapiens	Residual Activity	%	57.0
	12223657	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	88.0	CHEMBL3981	Homo sapiens	Residual Activity	%	88.0
	12223658	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	45.0	CHEMBL3981	Homo sapiens	Residual Activity	%	45.0
	12223659	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	72.0	CHEMBL3981	Homo sapiens	Residual Activity	%	72.0
	12223660	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	73.0	CHEMBL3981	Homo sapiens	Residual Activity	%	73.0
	12223661	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	69.0	CHEMBL3981	Homo sapiens	Residual Activity	%	69.0
	12223662	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	71.0	CHEMBL3981	Homo sapiens	Residual Activity	%	71.0
	12223663	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	60.0	CHEMBL3981	Homo sapiens	Residual Activity	%	60.0
	12223664	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	37.0	CHEMBL3981	Homo sapiens	Residual Activity	%	37.0
	12223665	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	65.0	CHEMBL3981	Homo sapiens	Residual Activity	%	65.0
	12223666	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	55.0	CHEMBL3981	Homo sapiens	Residual Activity	%	55.0
	12223667	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	53.0	CHEMBL3981	Homo sapiens	Residual Activity	%	53.0
	12223668	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	78.0	CHEMBL3981	Homo sapiens	Residual Activity	%	78.0
	12223669	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	53.0	CHEMBL3981	Homo sapiens	Residual Activity	%	53.0
	12223670	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	88.0	CHEMBL3981	Homo sapiens	Residual Activity	%	88.0
	12223671	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	60.0	CHEMBL3981	Homo sapiens	Residual Activity	%	60.0
	12223672	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	94.0	CHEMBL3981	Homo sapiens	Residual Activity	%	94.0
	12223673	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	94.0	CHEMBL3981	Homo sapiens	Residual Activity	%	94.0
	12223674	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	94.0	CHEMBL3981	Homo sapiens	Residual Activity	%	94.0
	12223675	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12223676	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12223677	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12223678	CHEMBL2219243	Millipore: Percentage of residual kinase activity of STK10 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12223679	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	68.0	CHEMBL3981	Homo sapiens	Residual Activity	%	68.0
	12223680	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	15.0	CHEMBL3981	Homo sapiens	Residual Activity	%	15.0
	12223681	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	57.0	CHEMBL3981	Homo sapiens	Residual Activity	%	57.0
	12223682	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12223683	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	10.0	CHEMBL3981	Homo sapiens	Residual Activity	%	10.0
	12223684	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	85.0	CHEMBL3981	Homo sapiens	Residual Activity	%	85.0
	12223685	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	7.0	CHEMBL3981	Homo sapiens	Residual Activity	%	7.0
	12223686	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	8.0	CHEMBL3981	Homo sapiens	Residual Activity	%	8.0
	12223687	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	99.0	CHEMBL3981	Homo sapiens	Residual Activity	%	99.0
	12223688	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	10.0	CHEMBL3981	Homo sapiens	Residual Activity	%	10.0
	12223689	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	86.0	CHEMBL3981	Homo sapiens	Residual Activity	%	86.0
	12223690	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	87.0	CHEMBL3981	Homo sapiens	Residual Activity	%	87.0
	12223691	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	33.0	CHEMBL3981	Homo sapiens	Residual Activity	%	33.0
	12223692	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	41.0	CHEMBL3981	Homo sapiens	Residual Activity	%	41.0
	12223693	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	33.0	CHEMBL3981	Homo sapiens	Residual Activity	%	33.0
	12223694	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	109.0	CHEMBL3981	Homo sapiens	Residual Activity	%	109.0
	12223695	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12223696	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	93.0	CHEMBL3981	Homo sapiens	Residual Activity	%	93.0
	12223697	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	87.0	CHEMBL3981	Homo sapiens	Residual Activity	%	87.0
	12223698	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	32.0	CHEMBL3981	Homo sapiens	Residual Activity	%	32.0
	12223699	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12223700	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	32.0	CHEMBL3981	Homo sapiens	Residual Activity	%	32.0
	12223701	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12223702	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	64.0	CHEMBL3981	Homo sapiens	Residual Activity	%	64.0
	12223703	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	105.0	CHEMBL3981	Homo sapiens	Residual Activity	%	105.0
	12223704	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	10.0	CHEMBL3981	Homo sapiens	Residual Activity	%	10.0
	12223705	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	20.0	CHEMBL3981	Homo sapiens	Residual Activity	%	20.0
	12223706	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	8.0	CHEMBL3981	Homo sapiens	Residual Activity	%	8.0
	12223707	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	85.0	CHEMBL3981	Homo sapiens	Residual Activity	%	85.0
	12223708	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	6.0	CHEMBL3981	Homo sapiens	Residual Activity	%	6.0
	12223709	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	93.0	CHEMBL3981	Homo sapiens	Residual Activity	%	93.0
	12223710	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	8.0	CHEMBL3981	Homo sapiens	Residual Activity	%	8.0
	12223711	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12223712	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	91.0	CHEMBL3981	Homo sapiens	Residual Activity	%	91.0
	12223713	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12223714	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	93.0	CHEMBL3981	Homo sapiens	Residual Activity	%	93.0
	12223715	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	37.0	CHEMBL3981	Homo sapiens	Residual Activity	%	37.0
	12223716	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12223717	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	106.0	CHEMBL3981	Homo sapiens	Residual Activity	%	106.0
	12223718	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	76.0	CHEMBL3981	Homo sapiens	Residual Activity	%	76.0
	12223719	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	100.0	CHEMBL3981	Homo sapiens	Residual Activity	%	100.0
	12223720	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12223721	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	8.0	CHEMBL3981	Homo sapiens	Residual Activity	%	8.0
	12223722	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL3981	Homo sapiens	Residual Activity	%	1.0
	12223723	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	7.0	CHEMBL3981	Homo sapiens	Residual Activity	%	7.0
	12223724	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	54.0	CHEMBL3981	Homo sapiens	Residual Activity	%	54.0
	12223725	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	107.0	CHEMBL3981	Homo sapiens	Residual Activity	%	107.0
	12223726	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	45.0	CHEMBL3981	Homo sapiens	Residual Activity	%	45.0
	12223727	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	102.0	CHEMBL3981	Homo sapiens	Residual Activity	%	102.0
	12223728	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	87.0	CHEMBL3981	Homo sapiens	Residual Activity	%	87.0
	12223729	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	22.0	CHEMBL3981	Homo sapiens	Residual Activity	%	22.0
	12223730	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	38.0	CHEMBL3981	Homo sapiens	Residual Activity	%	38.0
	12223731	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	7.0	CHEMBL3981	Homo sapiens	Residual Activity	%	7.0
	12223732	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	21.0	CHEMBL3981	Homo sapiens	Residual Activity	%	21.0
	12223733	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	99.0	CHEMBL3981	Homo sapiens	Residual Activity	%	99.0
	12226102	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	97.0	CHEMBL3981	Homo sapiens	Residual Activity	%	97.0
	12226103	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	33.0	CHEMBL3981	Homo sapiens	Residual Activity	%	33.0
	12226104	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	97.0	CHEMBL3981	Homo sapiens	Residual Activity	%	97.0
	12226105	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	70.0	CHEMBL3981	Homo sapiens	Residual Activity	%	70.0
	12226106	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	85.0	CHEMBL3981	Homo sapiens	Residual Activity	%	85.0
	12226107	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	47.0	CHEMBL3981	Homo sapiens	Residual Activity	%	47.0
	12226108	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	9.0	CHEMBL3981	Homo sapiens	Residual Activity	%	9.0
	12226109	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12226110	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	91.0	CHEMBL3981	Homo sapiens	Residual Activity	%	91.0
	12226111	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	106.0	CHEMBL3981	Homo sapiens	Residual Activity	%	106.0
	12226112	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	77.0	CHEMBL3981	Homo sapiens	Residual Activity	%	77.0
	12226113	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12226114	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	89.0	CHEMBL3981	Homo sapiens	Residual Activity	%	89.0
	12226115	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	35.0	CHEMBL3981	Homo sapiens	Residual Activity	%	35.0
	12226116	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	59.0	CHEMBL3981	Homo sapiens	Residual Activity	%	59.0
	12226117	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	93.0	CHEMBL3981	Homo sapiens	Residual Activity	%	93.0
	12226118	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	44.0	CHEMBL3981	Homo sapiens	Residual Activity	%	44.0
	12226119	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	15.0	CHEMBL3981	Homo sapiens	Residual Activity	%	15.0
	12226120	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	43.0	CHEMBL3981	Homo sapiens	Residual Activity	%	43.0
	12226121	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	55.0	CHEMBL3981	Homo sapiens	Residual Activity	%	55.0
	12226122	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	10.0	CHEMBL3981	Homo sapiens	Residual Activity	%	10.0
	12226123	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	89.0	CHEMBL3981	Homo sapiens	Residual Activity	%	89.0
	12226124	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	5.0	CHEMBL3981	Homo sapiens	Residual Activity	%	5.0
	12226125	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	88.0	CHEMBL3981	Homo sapiens	Residual Activity	%	88.0
	12226126	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3981	Homo sapiens	Residual Activity	%	0.0
	12226127	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	104.0	CHEMBL3981	Homo sapiens	Residual Activity	%	104.0
	12226128	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	6.0	CHEMBL3981	Homo sapiens	Residual Activity	%	6.0
	12226129	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	95.0	CHEMBL3981	Homo sapiens	Residual Activity	%	95.0
	12226130	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	59.0	CHEMBL3981	Homo sapiens	Residual Activity	%	59.0
	12226131	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	78.0	CHEMBL3981	Homo sapiens	Residual Activity	%	78.0
	12226132	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	94.0	CHEMBL3981	Homo sapiens	Residual Activity	%	94.0
	12226133	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12226134	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	79.0	CHEMBL3981	Homo sapiens	Residual Activity	%	79.0
	12226135	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL3981	Homo sapiens	Residual Activity	%	101.0
	12226136	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	71.0	CHEMBL3981	Homo sapiens	Residual Activity	%	71.0
	12226137	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	89.0	CHEMBL3981	Homo sapiens	Residual Activity	%	89.0
	12226138	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	29.0	CHEMBL3981	Homo sapiens	Residual Activity	%	29.0
	12226139	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	10.0	CHEMBL3981	Homo sapiens	Residual Activity	%	10.0
	12226140	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12226141	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	99.0	CHEMBL3981	Homo sapiens	Residual Activity	%	99.0
	12226142	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	85.0	CHEMBL3981	Homo sapiens	Residual Activity	%	85.0
	12226143	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	104.0	CHEMBL3981	Homo sapiens	Residual Activity	%	104.0
	12226144	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	108.0	CHEMBL3981	Homo sapiens	Residual Activity	%	108.0
	12226145	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	105.0	CHEMBL3981	Homo sapiens	Residual Activity	%	105.0
	12226146	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	79.0	CHEMBL3981	Homo sapiens	Residual Activity	%	79.0
	12226147	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	58.0	CHEMBL3981	Homo sapiens	Residual Activity	%	58.0
	12226148	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL3981	Homo sapiens	Residual Activity	%	1.0
	12226149	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	105.0	CHEMBL3981	Homo sapiens	Residual Activity	%	105.0
	12226150	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	100.0	CHEMBL3981	Homo sapiens	Residual Activity	%	100.0
	12226151	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	110.0	CHEMBL3981	Homo sapiens	Residual Activity	%	110.0
	12226152	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	96.0	CHEMBL3981	Homo sapiens	Residual Activity	%	96.0
	12226153	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12226154	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12226155	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	81.0	CHEMBL3981	Homo sapiens	Residual Activity	%	81.0
	12226156	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	56.0	CHEMBL3981	Homo sapiens	Residual Activity	%	56.0
	12226157	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	108.0	CHEMBL3981	Homo sapiens	Residual Activity	%	108.0
	12226158	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	105.0	CHEMBL3981	Homo sapiens	Residual Activity	%	105.0
	12226159	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	58.0	CHEMBL3981	Homo sapiens	Residual Activity	%	58.0
	12226160	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	36.0	CHEMBL3981	Homo sapiens	Residual Activity	%	36.0
	12226161	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	58.0	CHEMBL3981	Homo sapiens	Residual Activity	%	58.0
	12226162	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	95.0	CHEMBL3981	Homo sapiens	Residual Activity	%	95.0
	12226163	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	12.0	CHEMBL3981	Homo sapiens	Residual Activity	%	12.0
	12226164	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	89.0	CHEMBL3981	Homo sapiens	Residual Activity	%	89.0
	12226165	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	88.0	CHEMBL3981	Homo sapiens	Residual Activity	%	88.0
	12226166	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	99.0	CHEMBL3981	Homo sapiens	Residual Activity	%	99.0
	12226167	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12226168	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	15.0	CHEMBL3981	Homo sapiens	Residual Activity	%	15.0
	12226169	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	47.0	CHEMBL3981	Homo sapiens	Residual Activity	%	47.0
	12226170	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	95.0	CHEMBL3981	Homo sapiens	Residual Activity	%	95.0
	12226171	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	70.0	CHEMBL3981	Homo sapiens	Residual Activity	%	70.0
	12226172	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	77.0	CHEMBL3981	Homo sapiens	Residual Activity	%	77.0
	12226173	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	37.0	CHEMBL3981	Homo sapiens	Residual Activity	%	37.0
	12226174	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	107.0	CHEMBL3981	Homo sapiens	Residual Activity	%	107.0
	12226175	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	110.0	CHEMBL3981	Homo sapiens	Residual Activity	%	110.0
	12226176	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL3981	Homo sapiens	Residual Activity	%	0.0
	12226177	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	88.0	CHEMBL3981	Homo sapiens	Residual Activity	%	88.0
	12226178	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	93.0	CHEMBL3981	Homo sapiens	Residual Activity	%	93.0
	12226179	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	62.0	CHEMBL3981	Homo sapiens	Residual Activity	%	62.0
	12226180	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	90.0	CHEMBL3981	Homo sapiens	Residual Activity	%	90.0
	12226181	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	9.0	CHEMBL3981	Homo sapiens	Residual Activity	%	9.0
	12226182	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	17.0	CHEMBL3981	Homo sapiens	Residual Activity	%	17.0
	12226183	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	78.0	CHEMBL3981	Homo sapiens	Residual Activity	%	78.0
	12226184	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	13.0	CHEMBL3981	Homo sapiens	Residual Activity	%	13.0
	12226185	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	69.0	CHEMBL3981	Homo sapiens	Residual Activity	%	69.0
	12226186	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	68.0	CHEMBL3981	Homo sapiens	Residual Activity	%	68.0
	12226187	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	83.0	CHEMBL3981	Homo sapiens	Residual Activity	%	83.0
	12226188	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	53.0	CHEMBL3981	Homo sapiens	Residual Activity	%	53.0
	12226189	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	39.0	CHEMBL3981	Homo sapiens	Residual Activity	%	39.0
	12226190	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	19.0	CHEMBL3981	Homo sapiens	Residual Activity	%	19.0
	12226191	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	68.0	CHEMBL3981	Homo sapiens	Residual Activity	%	68.0
	12226192	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	55.0	CHEMBL3981	Homo sapiens	Residual Activity	%	55.0
	12226193	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	46.0	CHEMBL3981	Homo sapiens	Residual Activity	%	46.0
	12226194	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	39.0	CHEMBL3981	Homo sapiens	Residual Activity	%	39.0
	12226195	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	7.0	CHEMBL3981	Homo sapiens	Residual Activity	%	7.0
	12226196	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	48.0	CHEMBL3981	Homo sapiens	Residual Activity	%	48.0
	12226197	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	19.0	CHEMBL3981	Homo sapiens	Residual Activity	%	19.0
	12226198	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	58.0	CHEMBL3981	Homo sapiens	Residual Activity	%	58.0
	12226199	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	99.0	CHEMBL3981	Homo sapiens	Residual Activity	%	99.0
	12226200	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	80.0	CHEMBL3981	Homo sapiens	Residual Activity	%	80.0
	12226201	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	92.0	CHEMBL3981	Homo sapiens	Residual Activity	%	92.0
	12226202	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	75.0	CHEMBL3981	Homo sapiens	Residual Activity	%	75.0
	12226203	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	59.0	CHEMBL3981	Homo sapiens	Residual Activity	%	59.0
	12226204	CHEMBL2219244	Millipore: Percentage of residual kinase activity of STK10 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	93.0	CHEMBL3981	Homo sapiens	Residual Activity	%	93.0
	12671700	CHEMBL2341943	Binding affinity to LOK (unknown origin) at 10 uM relative to control	B	COc1ccc(-c2nc(SCc3ccccc3)nc(N3CCOCC3)c2C#N)cc1		CHEMBL2338504	=	Activity	%	45.0	CHEMBL3981	Homo sapiens	Activity	%	45.0
	12685259	CHEMBL2342048	Inhibition of LOK (unknown origin) assessed as residual activity at 100 nM after 1 hr by competitive binding assay relative to control	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336015	=	Activity	%	1.6	CHEMBL3981	Homo sapiens	Activity	%	1.6
	12693218	CHEMBL2343903	Inhibition of LOK (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL3981	Homo sapiens	IC50	nM	10000.0
	12729917	CHEMBL2350062	Inhibition of LOK (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	92.0	CHEMBL3981	Homo sapiens	Activity	%	92.0
	13436398	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436399	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436400	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436401	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436402	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436403	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436404	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436405	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436406	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436407	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436408	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13436409	CHEMBL2422258	Inhibition of LOK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	13439826	CHEMBL2426971	Competitive binding affinity to LOK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	13442633	CHEMBL2426971	Competitive binding affinity to LOK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	88.0	CHEMBL3981	Homo sapiens	INH	%	88.0
	13445659	CHEMBL2426971	Competitive binding affinity to LOK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	13448625	CHEMBL2429308	Competitive binding affinity to STK10 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	13451420	CHEMBL2429308	Competitive binding affinity to STK10 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	13451646	CHEMBL2426971	Competitive binding affinity to LOK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	13872109	CHEMBL3101416	Inhibition of human LOK assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	93.0	CHEMBL3981	Homo sapiens	Activity	%	93.0
	13953266	CHEMBL3132655	Inhibition of human LOK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	100.0	CHEMBL3981	Homo sapiens	Activity	%	100.0
	13954644	CHEMBL3132655	Inhibition of human LOK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	102.0	CHEMBL3981	Homo sapiens	Activity	%	102.0
	13954687	CHEMBL3132655	Inhibition of human LOK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	97.0	CHEMBL3981	Homo sapiens	Activity	%	97.0
	14582538	CHEMBL3242539	Inhibition of human LOK assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	40.5	CHEMBL3981	Homo sapiens	Activity	%	40.5
	15258378	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	8.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	8.1
	15258438	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.0
	15258498	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.4
	15258558	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	11.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	11.1
	15258618	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	5.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	5.9
	15258678	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	0.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.3
	15258738	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	2.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.0
	15258798	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	0.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.0
	15258858	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	4.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.1
	15258918	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	5.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	5.4
	15258978	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.8
	15259038	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	1.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.4
	15259098	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	4.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.0
	15259158	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	6.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	6.2
	15259218	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	15.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	15.5
	15259278	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	6.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	6.3
	15259338	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	0.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.0
	15259398	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.8
	15259458	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	4.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.3
	15259518	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	1.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.9
	15259578	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	1.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.5
	15259638	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	1.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.9
	15259698	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	7.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	7.2
	15259758	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	11.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	11.3
	15259818	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.4
	15259878	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.1
	15259938	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.5
	15259998	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	2.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.8
	15260058	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	1.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.8
	15260118	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	-0.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.2
	15260178	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	2.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.5
	15260238	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	9.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	9.0
	15260298	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	0.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.0
	15260358	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	2.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.8
	15260418	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	0.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.6
	15260478	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-0.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.7
	15260538	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	1.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.5
	15260598	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	1.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.0
	15260658	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	0.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.6
	15260718	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	2.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.7
	15260778	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	0.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.6
	15260838	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	7.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	7.2
	15260898	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	-0.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.1
Not Determined	15260958	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Thermal melting change			CHEMBL3981	Homo sapiens	Thermal melting change		
Not Determined	15261018	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Thermal melting change			CHEMBL3981	Homo sapiens	Thermal melting change		
Not Determined	15261078	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940		Thermal melting change			CHEMBL3981	Homo sapiens	Thermal melting change		
	15261138	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.0
	15261161	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	2.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.7
	15261221	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	5.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	5.9
	15261281	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	0.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.0
	15261341	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	6.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	6.1
	15261456	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	1.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.7
	15261516	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.7
	15261576	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	3.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.9
	15261636	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-1.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-1.1
	15261649	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	10.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	10.3
	15261709	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	7.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	7.4
	15261769	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.8
	15261829	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	4.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.0
	15261889	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	0.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.0
	15261945	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.8
	15262005	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	-0.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262065	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	1.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.0
	15262125	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	3.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.9
	15262198	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	4.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.0
	15262258	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	4.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.7
	15262318	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	4.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.7
	15262378	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	-0.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.3
	15262438	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	-0.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.7
	15262498	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.1
	15262558	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.5
	15262618	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	-0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262678	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	-0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262738	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	-0.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.8
	15262798	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	-0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.5
	15262858	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	1.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.3
	15262918	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	5.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	5.0
	15262978	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	-0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.5
	15263038	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	2.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.2
	15263098	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	2.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.3
	15263158	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.5
	15263218	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.7
	15263278	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	1.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.2
	15263338	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	1.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.1
	15263434	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	7.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	7.7
	15263489	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.9
	15263549	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	2.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.8
	15263609	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	3.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.0
	15263669	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	3.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.1
	15263743	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	1.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.2
	15263803	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	3.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.5
	15263863	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	1.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.6
	15263923	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.9
	15263977	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	1.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.9
	15264037	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	2.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.9
	15264097	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-1.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-1.8
	15264157	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.5
	15264217	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	1.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.6
	15264230	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	4.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.6
	15264290	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	4.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.2
	15264350	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.4
	15264410	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	6.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	6.1
	15264526	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	4.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.2
	15264586	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	10.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	10.9
	15264646	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.2
	15264706	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.8
	15264718	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	4.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.2
	15264778	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	1.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.2
	15264838	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.4
	15264898	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	6.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	6.4
	15264958	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	3.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.3
	15265014	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.7
	15265074	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	3.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.9
	15265134	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	1.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.1
	15265194	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	4.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.9
	15265267	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	2.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	2.0
	15265327	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.5
	15265387	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.5
	15265447	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	0.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.7
	15265503	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	-0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265563	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.1
	15265623	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	-0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265683	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	-0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265755	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.4
	15265815	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.9
	15265875	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.5
	15265935	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.4
	15265992	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	7.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	7.7
	15266052	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.6
	15266112	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.4
	15266172	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	0.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.0
	15266244	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	3.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.7
	15266304	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.5
	15266364	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	1.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.4
	15266424	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	5.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	5.3
	15266479	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	0.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.5
	15266539	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	0.0	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.0
	15266599	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	6.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	6.7
	15266659	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	6.7	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	6.7
	15266732	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	5.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	5.5
	15266792	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.8
	15266852	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	3.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.5
	15266912	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	3.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	3.6
	15266967	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	6.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	6.2
	15267027	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	7.5	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	7.5
	15267087	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	5.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	5.3
	15267147	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	4.1	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.1
	15267220	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	1.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.6
	15267280	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	1.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	1.9
	15267340	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	4.2	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.2
	15267400	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	4.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	4.4
	15267455	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	24.8	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	24.8
	15267515	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.9	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.9
	15267575	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	-0.3	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	-0.3
	15267635	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.6	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.6
	15267695	CHEMBL3430837	Delta TM value showing the stabilisation of LOK produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.4	CHEMBL3981	Homo sapiens	Thermal melting change	degrees C	0.4
	15756933	CHEMBL3631277	Inhibition of LOK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	92.78	CHEMBL3981	Homo sapiens	INH	%	92.78
	15757790	CHEMBL3631277	Inhibition of LOK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	74.8	CHEMBL3981	Homo sapiens	INH	%	74.8
	15758769	CHEMBL3631277	Inhibition of LOK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	28.45	CHEMBL3981	Homo sapiens	INH	%	28.45
254318	16325647	CHEMBL3707756	Kinase Screen Assay: KINOMEscan (Ambit Biosciences, San Diego, Calif.), a high-throughput method for screening small molecular agents against a large panel of human kinases, was utilized for compound 2. The technology is a competition binding assay that profiled the selectivity of compound 2 against 350 kinases, each fused to a proprietary tag. The quantity of each kinase bound to an immobilized, active site-directed ligand was measured in the presence and absence of compound 2.	B	Cc1nc(Nc2nc3ccc(-c4cccc(C(=O)Nc5cccc(C(F)(F)F)c5)c4)nc3s2)cc(N2CCNCC2)n1		CHEMBL2148120	=	Kd	nM	9.5	CHEMBL3981	Homo sapiens	Kd	nM	9.5
	16431885	CHEMBL3747978	Inhibition of human LOK using [RLGRDKYKTLRQIRQ] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3981	Homo sapiens	IC50	uM	10.0
	16495118	CHEMBL3776236	Inhibition of N-terminal His6-tagged recombinant human LOK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-1.0	CHEMBL3981	Homo sapiens	Activity	%	-1.0
	16496037	CHEMBL3776236	Inhibition of N-terminal His6-tagged recombinant human LOK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-5.0	CHEMBL3981	Homo sapiens	Activity	%	-5.0
	16508224	CHEMBL3776236	Inhibition of N-terminal His6-tagged recombinant human LOK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	23.0	CHEMBL3981	Homo sapiens	Activity	%	23.0
	16534408	CHEMBL3789292	Inhibition of human LOK at 1 uM after 30 mins by fluorescence assay in presence of ATP	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	Inhibition	%	96.0	CHEMBL3981	Homo sapiens	INH	%	96.0
	16614522	CHEMBL3816720	Inhibition of human LOK at 1 uM using [RLGRDKYKTLRQIRQ] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	35.0	CHEMBL3981	Homo sapiens	INH	%	35.0
	16632173	CHEMBL3824673	Inhibition of STK10 (unknown origin)	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Ki	nM	10000.0	CHEMBL3981	Homo sapiens	Ki	nM	10000.0
	16632174	CHEMBL3824672	Binding affinity to STK10 (unknown origin)	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	81.0	CHEMBL3981	Homo sapiens	Kd	nM	81.0
Not Determined	16854259	CHEMBL3878992	Inhibition of LOK (unknown origin) measured after 1 hr by FRET based Z'Lyte assay	B	Cc1ccc(C(=O)N2CCC(Oc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)CC2)cn1		CHEMBL3939150		IC50			CHEMBL3981	Homo sapiens	IC50		
	16854260	CHEMBL3878991	Inhibition of LOK (unknown origin) assessed as residual activity at 1 uM measured after 1 hr by FRET based Z'Lyte assay relative to control	B	Cc1ccc(C(=O)N2CCC(Oc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)CC2)cn1		CHEMBL3939150	=	Activity	%	0.6	CHEMBL3981	Homo sapiens	Activity	%	0.6
Inactive	17940514	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940515	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	4392.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	4392.0
Inactive	17940516	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940517	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940518	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940519	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	481.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	481.0
Active	17940520	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	3428.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	3428.0
Inactive	17940521	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940522	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940523	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	71.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	71.0
Inactive	17940524	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940525	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940526	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940527	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	10160.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	10160.0
Active	17940528	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	3078.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	3078.0
Inactive	17940529	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940530	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940531	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940532	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	=	Kd	nM	2634.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2634.0
Inactive	17940533	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940534	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940535	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940536	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940537	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	Kd	nM	57453.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	57453.0
Inactive	17940538	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940539	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940540	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940541	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940542	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940543	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940544	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	=	Kd	nM	728.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	728.0
Inactive	17940545	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940546	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940547	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940548	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940549	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940550	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940551	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940552	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	=	Kd	nM	28643.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	28643.0
Inactive	17940553	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940554	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940555	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	793.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	793.0
Active	17940556	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	3958.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	3958.0
Inactive	17940557	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940558	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2787.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2787.0
Inactive	17940559	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940560	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940561	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940562	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	949.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	949.0
Active	17940563	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	96.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	96.0
Inactive	17940564	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940565	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940566	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940567	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	2919.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2919.0
Inactive	17940568	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940569	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940570	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	4622.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	4622.0
Inactive	17940571	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940572	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940573	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	=	Kd	nM	8443.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	8443.0
Active	17940574	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	2470.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2470.0
Inactive	17940575	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940576	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940577	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940578	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	823.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	823.0
Inactive	17940579	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940580	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940581	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	5236.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	5236.0
Inactive	17940582	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940583	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940584	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940585	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940586	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940587	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940588	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940589	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940590	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940591	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940592	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940593	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940594	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940595	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	879.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	879.0
Inactive	17940596	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940597	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940598	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	Kd	nM	2269.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2269.0
Active	17940599	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	42550.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	42550.0
Active	17940600	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	379.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	379.0
Inactive	17940601	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940602	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940603	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	1282.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	1282.0
Active	17940604	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	1905.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	1905.0
Inactive	17940605	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940606	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940607	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940608	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940609	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940610	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	=	Kd	nM	2159.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2159.0
Active	17940611	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	136.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	136.0
Inactive	17940612	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940613	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	3252.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	3252.0
Inactive	17940614	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940615	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940616	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	721.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	721.0
Inactive	17940617	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940618	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940619	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940620	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940621	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940622	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940623	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940624	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940625	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940626	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	515.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	515.0
Inactive	17940627	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940628	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940629	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940630	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940631	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940632	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940633	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940634	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	=	Kd	nM	45148.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	45148.0
Active	17940635	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	=	Kd	nM	227.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	227.0
Active	17940636	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	82.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	82.0
Inactive	17940637	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940638	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	360.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	360.0
Inactive	17940639	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940640	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	2823.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2823.0
Inactive	17940641	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940642	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940643	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940644	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940645	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940646	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940647	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940648	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940649	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940650	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940651	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940652	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940653	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940654	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	1588.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	1588.0
Inactive	17940655	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940656	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940657	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940658	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940659	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940660	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940661	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940662	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	309.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	309.0
Inactive	17940663	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940664	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940665	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	Kd	nM	1912.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	1912.0
Inactive	17940666	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940667	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940668	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940669	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	4001.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	4001.0
Inactive	17940670	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940671	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940672	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940673	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940674	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	98.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	98.0
Active	17940675	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	11681.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	11681.0
Inactive	17940676	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940677	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940678	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940679	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940680	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	877.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	877.0
Active	17940681	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	9954.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	9954.0
Active	17940682	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	317.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	317.0
Inactive	17940683	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940684	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2370.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2370.0
Active	17940685	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	3382.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	3382.0
Inactive	17940686	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940687	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	1281.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	1281.0
Active	17940688	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	1091.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	1091.0
Inactive	17940689	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940690	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940691	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940692	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940693	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940694	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940695	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940696	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940697	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940698	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940699	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940700	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940701	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940702	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940703	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940704	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940705	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940706	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940707	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940708	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940709	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3965.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	3965.0
Inactive	17940710	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940711	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940712	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940713	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940714	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	14.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	14.0
Inactive	17940715	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940716	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940717	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2828.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2828.0
Inactive	17940718	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940719	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940720	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940721	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940722	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940723	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940724	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940725	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940726	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940727	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940728	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940729	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940730	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940731	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	3.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	3.0
Inactive	17940732	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940733	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940734	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940735	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940736	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940737	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940738	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940739	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940740	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940741	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940742	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	2713.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2713.0
Inactive	17940743	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940744	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940745	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940746	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940747	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940748	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940749	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17940750	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Active	17940751	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2852.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	2852.0
Active	17940752	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	5820.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	5820.0
Active	17940753	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	23701.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	23701.0
Active	17940754	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	149.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	149.0
Inactive	17940755	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17940756	CHEMBL3991890	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	5077.0	CHEMBL3981	Homo sapiens	Kd apparent	nM	5077.0
	18048733	CHEMBL4011079	Inhibition of STK10 (unknown origin) at 0.5 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Inhibition	%	46.0	CHEMBL3981	Homo sapiens	INH	%	46.0
	18114284	CHEMBL4025210	Inhibition of wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	94.0	CHEMBL3981	Homo sapiens	Activity	%	94.0
	18141787	CHEMBL4031402	Inhibition of human LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	Activity	%	0.15	CHEMBL3981	Homo sapiens	Activity	%	0.15
	18153085	CHEMBL4034365	Inhibition of LOK Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	9.4	CHEMBL3981	Homo sapiens	INH	%	9.4
	18153294	CHEMBL4034364	Inhibition of LOK Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	1.5	CHEMBL3981	Homo sapiens	INH	%	1.5
	18203734	CHEMBL4044021	Inhibition of wild-type human partial length LOK (E16 to V314 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	34.0	CHEMBL3981	Homo sapiens	Activity	%	34.0
	18211662	CHEMBL4045724	Inhibition of LOK conserved Lys2 (DLKAGNVLMTLEGDIR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	14.5	CHEMBL3981	Homo sapiens	INH	%	14.5
	18211672	CHEMBL4045723	Inhibition of LOK conserved Lys1 (NKETGALAAAKVIETK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	32.2	CHEMBL3981	Homo sapiens	INH	%	32.2
	18211868	CHEMBL4045964	Inhibition of LOK conserved Lys1 (NKETGALAAAKVIETK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-38.5	CHEMBL3981	Homo sapiens	INH	%	-38.5
	18211869	CHEMBL4045965	Inhibition of LOK conserved Lys2 (DLKAGNVLMTLEGDIR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	13.8	CHEMBL3981	Homo sapiens	INH	%	13.8
	18232354	CHEMBL4050452	Binding affinity to wild-type human LOK expressed in bacterial system assessed as control score at 1 uM by KINOMEScan assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(OCc4ccccn4)c(Cl)c3)c3c(N)ncnc32)C1		CHEMBL4068839	=	Activity	%	0.95	CHEMBL3981	Homo sapiens	Activity	%	0.95
	18253297	CHEMBL4054932	Inhibition of wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	48.0	CHEMBL3981	Homo sapiens	Activity	%	48.0
	18253298	CHEMBL4054932	Inhibition of wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	75.0	CHEMBL3981	Homo sapiens	Activity	%	75.0
	18265851	CHEMBL4057301	Inhibition of LOK (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	9.3	CHEMBL3981	Homo sapiens	INH	%	9.3
	18266109	CHEMBL4057559	Inhibition of LOK (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	9.7	CHEMBL3981	Homo sapiens	INH	%	9.7
	18275007	CHEMBL4118381	Inhibition of LOK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKAGNVLMTLEGDIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	40.4	CHEMBL3981	Homo sapiens	INH	%	40.4
	18275008	CHEMBL4118381	Inhibition of LOK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKAGNVLMTLEGDIR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	11.6	CHEMBL3981	Homo sapiens	INH	%	11.6
	18275009	CHEMBL4118381	Inhibition of LOK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKAGNVLMTLEGDIR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	21.4	CHEMBL3981	Homo sapiens	INH	%	21.4
	18282853	CHEMBL4120438	Inhibition of LOK (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	9.3	CHEMBL3981	Homo sapiens	INH	%	9.3
	18283024	CHEMBL4120609	Inhibition of LOK (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	4.3	CHEMBL3981	Homo sapiens	INH	%	4.3
	18283248	CHEMBL4120833	Inhibition of LOK (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	3.7	CHEMBL3981	Homo sapiens	INH	%	3.7
	18409087	CHEMBL4151621	Inhibition of LOK (unknown origin) at 1 uM	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	>	Inhibition	%	90.0	CHEMBL3981	Homo sapiens	INH	%	90.0
	18409099	CHEMBL4151633	Binding affinity to human LOK	B	CC(C)c1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2cnccn12		CHEMBL4168305	=	Kd	nM	10.0	CHEMBL3981	Homo sapiens	Kd	nM	10.0
	18440276	CHEMBL4157100	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	98.0	CHEMBL3981	Homo sapiens	Activity	%	98.0
	18484232	CHEMBL4185879	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL3981	Homo sapiens	Activity	%	100.0
	18484716	CHEMBL4185879	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	78.0	CHEMBL3981	Homo sapiens	Activity	%	78.0
	18507735	CHEMBL4191027	Inhibition of recombinant human LOK (1 to 348 residues) at 1 uM using RLGRDKYKTLRQIRQ as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-5.0	CHEMBL3981	Homo sapiens	INH	%	-5.0
	18653557	CHEMBL4230125	Inhibition of LOK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	97.0	CHEMBL3981	Homo sapiens	INH	%	97.0
	18653558	CHEMBL4230125	Inhibition of LOK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	59.0	CHEMBL3981	Homo sapiens	INH	%	59.0
	18655456	CHEMBL4230779	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	28.0	CHEMBL3981	Homo sapiens	Activity	%	28.0
	18694000	CHEMBL4253453	Inhibition of LOK1 (unknown origin) at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	11.0	CHEMBL3981	Homo sapiens	INH	%	11.0
	18694082	CHEMBL4253535	Inhibition of LOK1 (unknown origin) at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	81.0	CHEMBL3981	Homo sapiens	INH	%	81.0
	18751025	CHEMBL4263843	Inhibition of LOK (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	68.0	CHEMBL3981	Homo sapiens	INH	%	68.0
	18752029	CHEMBL4264368	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL3981	Homo sapiens	Activity	%	100.0
	18761531	CHEMBL4266584	Inhibition of recombinant human N-terminal His6-tagged LOK (1 to 348 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	54.0	CHEMBL3981	Homo sapiens	INH	%	54.0
	18761802	CHEMBL4266584	Inhibition of recombinant human N-terminal His6-tagged LOK (1 to 348 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	21.0	CHEMBL3981	Homo sapiens	INH	%	21.0
	18761965	CHEMBL4266584	Inhibition of recombinant human N-terminal His6-tagged LOK (1 to 348 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	6.0	CHEMBL3981	Homo sapiens	INH	%	6.0
	18858032	CHEMBL4307878	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	88.0	CHEMBL3981	Homo sapiens	Activity	%	88.0
	18892898	CHEMBL4314864	Inhibition of recombinant human LOK (1 to 348 residues) assessed as residual activity at 10 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	91.5	CHEMBL3981	Homo sapiens	Activity	%	91.5
	18938041	CHEMBL4327747	Inhibition of human LOK assessed as residual activity at 1 uM using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	98.1	CHEMBL3981	Homo sapiens	Activity	%	98.1
	18938042	CHEMBL4327747	Inhibition of human LOK assessed as residual activity at 1 uM using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	103.79	CHEMBL3981	Homo sapiens	Activity	%	103.79
	18938592	CHEMBL4328111	Inhibition of human LOK assessed as residual activity at 100 uM using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3981	Homo sapiens	Activity	%	65.0
	18938972	CHEMBL4328475	Inhibition of human LOK using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	9.01	CHEMBL3981	Homo sapiens	IC50	10'-9M	9.01
	18958943	CHEMBL4333465	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	82.0	CHEMBL3981	Homo sapiens	Activity	%	82.0
	18964407	CHEMBL4335142	Inhibition of recombinant human LOK (1 to 348 residues) assessed as residual activity at 1 uM using RLGRDKYKTLRQIRQ as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	95.0	CHEMBL3981	Homo sapiens	Activity	%	95.0
	18964408	CHEMBL4335142	Inhibition of recombinant human LOK (1 to 348 residues) assessed as residual activity at 1 uM using RLGRDKYKTLRQIRQ as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	95.0	CHEMBL3981	Homo sapiens	Activity	%	95.0
	18971957	CHEMBL4336967	Inhibition of recombinant human LOK (1 to 348 residues) assessed as residual activity at 10 uM using RLGRDKYKTLRQI as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	54.0	CHEMBL3981	Homo sapiens	Activity	%	54.0
Not Active	19039724	CHEMBL4351918	Inhibition of recombinant human LOK (1 to 348 residues) at 10 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3981	Homo sapiens	INH		
Active	19041163	CHEMBL4352424	Inhibition of human LOK at 10 uM using RLGRDKYKTLRQIRQ as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3981	Homo sapiens	INH		
	19059656	CHEMBL4357957	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	96.0	CHEMBL3981	Homo sapiens	Activity	%	96.0
	19069683	CHEMBL4361177	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4577779	<	Activity	%	1.0	CHEMBL3981	Homo sapiens	Activity	%	1.0
	19090221	CHEMBL4365795	Inhibition of wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	40.0	CHEMBL3981	Homo sapiens	Activity	%	40.0
	19091984	CHEMBL4366458	Inhibition of human LOK at 100 nM using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-11.15	CHEMBL3981	Homo sapiens	INH	%	-11.15
	19095139	CHEMBL4367360	Inhibition of human STK10 at 1 uM using RLGRDKYKTLRQIRQ as substrate in presence of [gamma-33P]ATP relative to control	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO		CHEMBL4514780	=	Inhibition	%	70.0	CHEMBL3981	Homo sapiens	INH	%	70.0
	19114480	CHEMBL4371440	Binding affinity to LOK in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	3780.0	CHEMBL3981	Homo sapiens	Kd(free)	uM	3.78
	19114709	CHEMBL4371440	Binding affinity to LOK in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	3039.0	CHEMBL3981	Homo sapiens	Kd(free)	uM	3.039
Active	19114755	CHEMBL4371390	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115		Activity			CHEMBL3981	Homo sapiens	Activity		
Active	19114780	CHEMBL4371390	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225		Activity			CHEMBL3981	Homo sapiens	Activity		
	19144942	CHEMBL4377958	Inhibition of recombinant human LOK (1 to 348 residues) at 1 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	71.0	CHEMBL3981	Homo sapiens	INH	%	71.0
	19146834	CHEMBL4378958	Inhibition of recombinant human LOK (1 to 348 residues) at 10 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1	Outside typical range	CHEMBL4459587	=	Inhibition	%	-13.0	CHEMBL3981	Homo sapiens	INH	%	-13.0
	19147907	CHEMBL4379381	Inhibition of recombinant human LOK (1 to 348 residues) using RLGRDKYKTLRQI as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3981	Homo sapiens	IC50	uM	10.0
	19159484	CHEMBL4382588	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	0.0	CHEMBL3981	Homo sapiens	Activity	%	0.0
	19191523	CHEMBL4389307	Inhibition of wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.45	CHEMBL3981	Homo sapiens	INH	%	0.45
	19191970	CHEMBL4389784	Inhibition of wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	11.0	CHEMBL3981	Homo sapiens	INH	%	11.0
	19200226	CHEMBL4391410	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	99.0	CHEMBL3981	Homo sapiens	Activity	%	99.0
	19242729	CHEMBL4400064	Inhibition of human recombinant LOK (1 to 348 residues) assessed as residual activity at 10 uM using RLGRDKYKTLRQI as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	97.0	CHEMBL3981	Homo sapiens	Activity	%	97.0
	19266481	CHEMBL4405431	Inhibition of wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	19276025	CHEMBL4408028	Inhibition of recombinant human LOK (1 to 348 residues) at 1 uM using RLGRDKYKTLRQIRQ as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	93.0	CHEMBL3981	Homo sapiens	INH	%	93.0
	19290719	CHEMBL4410996	Inhibition of recombinant human LOK (1 to 348 residues) assessed as residual enzyme activity at 10 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	O=C1CN(c2cn[nH]c(=O)c2Cl)CCN1Cc1ccccc1C(F)(F)F		CHEMBL4530872	=	Activity	%	33.0	CHEMBL3981	Homo sapiens	Activity	%	33.0
	19310335	CHEMBL4416122	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 10000 nM by Kinomescan method relative to control	B	CN(C)C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1		CHEMBL4521381	<	Activity	%	10.0	CHEMBL3981	Homo sapiens	Activity	%	10.0
	19407710	CHEMBL4426907	Binding affinity to human LOK	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241	=	Kd	nM	10.0	CHEMBL3981	Homo sapiens	Kd	nM	10.0
	19433052	CHEMBL4429595	Inhibition of partial length human LOK expressed in bacterial expression system assessed as activity remaining at 1 uM by kinome scan assay	B	CCC(=O)NCC1CCN(c2ccc(NC(=O)Nc3cccc(Oc4ccnc5cc(OC)c(OC)cc45)c3)cc2C(F)(F)F)CC1		CHEMBL4445808	=	Activity	%	0.35	CHEMBL3981	Homo sapiens	Activity	%	0.35
	20598206	CHEMBL4602933	Inhibition of human STK10	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL3981	Homo sapiens	IC50	uM	1.0
	22423085	CHEMBL4674100	Inhibition of human LOK using RLGRDKYKTLRQIRQ as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL3981	Homo sapiens	INH	%	80.0
	22423503	CHEMBL4674327	Inhibition of human LOK using RLGRDKYKTLRQIRQ as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	15.57	CHEMBL3981	Homo sapiens	Activity	%	15.57
	22423504	CHEMBL4674327	Inhibition of human LOK using RLGRDKYKTLRQIRQ as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	9.65	CHEMBL3981	Homo sapiens	Activity	%	9.65
	22770398	CHEMBL4704295	Inhibition of LOK (unknown origin) at 1 uM relative to control	B	Cc1cn([C@@H](C)[C@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12		CHEMBL4778578	=	Inhibition	%	87.0	CHEMBL3981	Homo sapiens	INH	%	87.0
	22801998	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Delta Tm	degrees C	10.0	CHEMBL3981	Homo sapiens	deltaTm	degrees C	10.0
	22801999	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2ccccc2)n1		CHEMBL312873	=	Delta Tm	degrees C	1.1	CHEMBL3981	Homo sapiens	deltaTm	degrees C	1.1
	22802000	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccccc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4790278	=	Delta Tm	degrees C	8.6	CHEMBL3981	Homo sapiens	deltaTm	degrees C	8.6
	22802001	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)n(-c2ccccc2)n1		CHEMBL102547	=	Delta Tm	degrees C	0.8	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.8
	22802002	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4751695	=	Delta Tm	degrees C	0.8	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.8
	22802003	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)cc2)n(-c2ccccc2)n1		CHEMBL4741055	=	Delta Tm	degrees C	6.5	CHEMBL3981	Homo sapiens	deltaTm	degrees C	6.5
	22802004	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccccc2)n1		CHEMBL4762688	=	Delta Tm	degrees C	-0.5	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.5
	22802005	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCc3ccccc3)cc2)n(-c2ccccc2)n1		CHEMBL4785824	=	Delta Tm	degrees C	0.4	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.4
	22802006	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1cc(C)cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4783603	=	Delta Tm	degrees C	-0.3	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.3
	22802007	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(F)cc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4759399	=	Delta Tm	degrees C	4.1	CHEMBL3981	Homo sapiens	deltaTm	degrees C	4.1
	22802008	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)c(F)c2)n(-c2ccccc2)n1		CHEMBL4765042	=	Delta Tm	degrees C	3.4	CHEMBL3981	Homo sapiens	deltaTm	degrees C	3.4
	22802009	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2ccccc2)n1		CHEMBL314023	=	Delta Tm	degrees C	7.2	CHEMBL3981	Homo sapiens	deltaTm	degrees C	7.2
	22802010	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(S(=O)(=O)NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4750748	=	Delta Tm	degrees C	-0.9	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.9
	22802011	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	COc1cccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4746299	=	Delta Tm	degrees C	3.7	CHEMBL3981	Homo sapiens	deltaTm	degrees C	3.7
	22802012	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Delta Tm	degrees C	4.7	CHEMBL3981	Homo sapiens	deltaTm	degrees C	4.7
	22802013	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1		CHEMBL4759890	=	Delta Tm	degrees C	-0.5	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.5
	22802014	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4784705	=	Delta Tm	degrees C	1.1	CHEMBL3981	Homo sapiens	deltaTm	degrees C	1.1
	22802015	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4784725	=	Delta Tm	degrees C	-0.6	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.6
	22802016	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4744374	=	Delta Tm	degrees C	-0.6	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.6
	22802017	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(C(C)(C)C)n1		CHEMBL4742158	=	Delta Tm	degrees C	-0.7	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.7
	22802018	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4797231	=	Delta Tm	degrees C	-0.3	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.3
	22802019	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4787226	=	Delta Tm	degrees C	2.6	CHEMBL3981	Homo sapiens	deltaTm	degrees C	2.6
	22802020	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4777689	=	Delta Tm	degrees C	-0.7	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.7
	22802021	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccccc2)n1		CHEMBL4764223	=	Delta Tm	degrees C	2.5	CHEMBL3981	Homo sapiens	deltaTm	degrees C	2.5
	22802022	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(F)cc(F)c2)cc1		CHEMBL4741029	=	Delta Tm	degrees C	0.6	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.6
	22802023	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4754583	=	Delta Tm	degrees C	1.1	CHEMBL3981	Homo sapiens	deltaTm	degrees C	1.1
	22802024	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4780554	=	Delta Tm	degrees C	1.7	CHEMBL3981	Homo sapiens	deltaTm	degrees C	1.7
	22802025	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4798321	=	Delta Tm	degrees C	0.6	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.6
	22802026	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(C(C)(C)C)n1		CHEMBL4791471	=	Delta Tm	degrees C	-0.2	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.2
	22802027	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4757882	=	Delta Tm	degrees C	0.2	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.2
	22802028	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4740104	=	Delta Tm	degrees C	-0.7	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.7
	22802029	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(F)cc(F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4789547	=	Delta Tm	degrees C	0.6	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.6
	22802030	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Delta Tm	degrees C	22.9	CHEMBL3981	Homo sapiens	deltaTm	degrees C	22.9
	22802031	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4787113	=	Delta Tm	degrees C	0.0	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.0
	22802032	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(N)cc2)n1		CHEMBL4756419	=	Delta Tm	degrees C	2.0	CHEMBL3981	Homo sapiens	deltaTm	degrees C	2.0
	22802033	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4740208	=	Delta Tm	degrees C	-0.6	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.6
	22802034	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(OC(F)(F)F)cc2)n1		CHEMBL4756465	=	Delta Tm	degrees C	0.0	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.0
	22802035	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C#N)cc2)n1		CHEMBL4786417	=	Delta Tm	degrees C	2.2	CHEMBL3981	Homo sapiens	deltaTm	degrees C	2.2
	22802036	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(S(C)(=O)=O)cc2)n1		CHEMBL4757100	=	Delta Tm	degrees C	4.1	CHEMBL3981	Homo sapiens	deltaTm	degrees C	4.1
	22802037	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NC(=O)C3CC3)cc2)n1		CHEMBL4788823	=	Delta Tm	degrees C	3.4	CHEMBL3981	Homo sapiens	deltaTm	degrees C	3.4
	22802038	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NS(C)(=O)=O)cc2)n1		CHEMBL4754044	=	Delta Tm	degrees C	8.9	CHEMBL3981	Homo sapiens	deltaTm	degrees C	8.9
	22802039	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)C(=O)Nc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4782612	=	Delta Tm	degrees C	5.1	CHEMBL3981	Homo sapiens	deltaTm	degrees C	5.1
	22802040	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc(OC(F)(F)F)cc1		CHEMBL4790434	=	Delta Tm	degrees C	0.0	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.0
	22802041	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	N#Cc1ccc(-n2nc(C3CC3)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4742987	=	Delta Tm	degrees C	-0.7	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.7
	22802042	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4755558	=	Delta Tm	degrees C	-0.9	CHEMBL3981	Homo sapiens	deltaTm	degrees C	-0.9
	22802043	CHEMBL4711697	Inhibition of STK10 (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C(F)(F)F)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4794564	=	Delta Tm	degrees C	0.5	CHEMBL3981	Homo sapiens	deltaTm	degrees C	0.5
	22809800	CHEMBL4713335	Inhibition of recombinant human LOK (1 to 348 residues) assessed as residual activity at 1 uM using RLGRDKYKTLRQI as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	62.0	CHEMBL3981	Homo sapiens	Activity	%	62.0
	22820508	CHEMBL4716256	Inhibition of recombinant N-terminal 6His-tagged human LOK (1 to 348 residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	69.0	CHEMBL3981	Homo sapiens	Activity	%	69.0
	22820509	CHEMBL4716256	Inhibition of recombinant N-terminal 6His-tagged human LOK (1 to 348 residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	22.0	CHEMBL3981	Homo sapiens	Activity	%	22.0
	22843514	CHEMBL4720503	Inhibition of LOK (unknown origin) at 1 uM relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	92.7	CHEMBL3981	Homo sapiens	INH	%	92.7
	22843515	CHEMBL4720503	Inhibition of LOK (unknown origin) at 1 uM relative to control	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Inhibition	%	80.8	CHEMBL3981	Homo sapiens	INH	%	80.8
	22843691	CHEMBL4720677	Inhibition of human LOK using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.93	CHEMBL3981	Homo sapiens	IC50	10^-9M	6.93
	22844041	CHEMBL4721027	Inhibition of human LOK assessed as residual activity using RLGRDKYKTLRQIRQ as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	83.01	CHEMBL3981	Homo sapiens	Activity	%	83.01
	22844755	CHEMBL4721430	Inhibition of wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	92.66	CHEMBL3981	Homo sapiens	Activity	%	92.66
	22874837	CHEMBL4725528	Inhibition of human LOK assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	34.0	CHEMBL3981	Homo sapiens	Activity	%	34.0
	22952886	CHEMBL4766823	Inhibition of recombinant human LOK (1 to 348 residues) assessed as residual activity at 10 uM using RLGRDKYKTLRQI as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	15.0	CHEMBL3981	Homo sapiens	Activity	%	15.0
	22974463	CHEMBL4771301	Binding affinity to wild-type human partial length LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4792974	<	Activity	%	35.0	CHEMBL3981	Homo sapiens	Activity	%	35.0
	23120554	CHEMBL4804409	Inhibition of LOK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	61500.0	CHEMBL3981	Homo sapiens	IC50	uM	61.5
	23120555	CHEMBL4804409	Inhibition of LOK in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	85500.0	CHEMBL3981	Homo sapiens	IC50	uM	85.5
	23120556	CHEMBL4804409	Inhibition of LOK in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	9700.0	CHEMBL3981	Homo sapiens	IC50	uM	9.7
	23120557	CHEMBL4804409	Inhibition of LOK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	96900.0	CHEMBL3981	Homo sapiens	IC50	uM	96.9
	23120558	CHEMBL4804409	Inhibition of LOK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	98700.0	CHEMBL3981	Homo sapiens	IC50	uM	98.7
	23120559	CHEMBL4804409	Inhibition of LOK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	98500.0	CHEMBL3981	Homo sapiens	IC50	uM	98.5
	23121593	CHEMBL4804591	Inhibition of LOK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	23121594	CHEMBL4804591	Inhibition of LOK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	75.0	CHEMBL3981	Homo sapiens	INH	%	75.0
	23121595	CHEMBL4804591	Inhibition of LOK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL3981	Homo sapiens	INH	%	0.0
	23121596	CHEMBL4804591	Inhibition of LOK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	>	Inhibition	%	90.0	CHEMBL3981	Homo sapiens	INH	%	90.0
	23121597	CHEMBL4804591	Inhibition of LOK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	>	Inhibition	%	90.0	CHEMBL3981	Homo sapiens	INH	%	90.0
	23121598	CHEMBL4804591	Inhibition of LOK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	Inhibition	%	90.0	CHEMBL3981	Homo sapiens	INH	%	90.0
	23122642	CHEMBL4804993	Inhibition of human LOK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	94.0	CHEMBL3981	Homo sapiens	Activity	%	94.0
	23123337	CHEMBL4805581	Inhibition of human LOK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	90.0	CHEMBL3981	Homo sapiens	Activity	%	90.0
	23123796	CHEMBL4806040	Inhibition of DNA-tagged human LOK assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3981	Homo sapiens	Activity	%	100.0
	23124764	CHEMBL4806598	Inhibition of human LOK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	84.0	CHEMBL3981	Homo sapiens	Activity	%	84.0
	23124765	CHEMBL4806598	Inhibition of human LOK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	69.0	CHEMBL3981	Homo sapiens	Activity	%	69.0
	23128774	CHEMBL4808059	Inhibition of LOK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	93.0	CHEMBL3981	Homo sapiens	INH	%	93.0
	23128775	CHEMBL4808059	Inhibition of LOK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	66.0	CHEMBL3981	Homo sapiens	INH	%	66.0
	23128776	CHEMBL4808059	Inhibition of LOK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3n[nH]nc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4853006	=	Inhibition	%	26.0	CHEMBL3981	Homo sapiens	INH	%	26.0
	23128777	CHEMBL4808059	Inhibition of LOK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(C(F)(F)F)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4870763	=	Inhibition	%	58.0	CHEMBL3981	Homo sapiens	INH	%	58.0
	23128778	CHEMBL4808059	Inhibition of LOK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(NC)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4855979	=	Inhibition	%	50.0	CHEMBL3981	Homo sapiens	INH	%	50.0
	23128779	CHEMBL4808059	Inhibition of LOK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)n(CCN(C)C)c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4847460	=	Inhibition	%	47.0	CHEMBL3981	Homo sapiens	INH	%	47.0
	23128780	CHEMBL4808059	Inhibition of LOK (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	55.0	CHEMBL3981	Homo sapiens	INH	%	55.0
	23128781	CHEMBL4808059	Inhibition of LOK (unknown origin) at 0.5 uM relative to control	B	CSc1nc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3Br)cc2)c(-c2ccc(F)cc2)o1		CHEMBL4875968	=	Inhibition	%	36.0	CHEMBL3981	Homo sapiens	INH	%	36.0
	23239312	CHEMBL4828837	Inhibition of ADP(ATP)-biotin probe binding to LOK in human Kelly cells at 1 uM incubated for 6 hrs by KiNativ profiling analysis	B	CN(C)C/C=C/C(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1		CHEMBL4754873	=	Inhibition	%	33.9	CHEMBL3981	Homo sapiens	INH	%	33.9
	23290698	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1		CHEMBL156563	=	Ki	nM	760.0	CHEMBL3981	Homo sapiens	Ki	nM	760.0
	23290699	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc(O)c(Cl)c2)C(=O)NC1=O		CHEMBL157089	=	Ki	nM	73.0	CHEMBL3981	Homo sapiens	Ki	nM	73.0
	23290700	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(O)c2)C(=O)NC1=O		CHEMBL160231	=	Ki	nM	480.0	CHEMBL3981	Homo sapiens	Ki	nM	480.0
	23290701	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(Cl)c1		CHEMBL156506	=	Ki	nM	310.0	CHEMBL3981	Homo sapiens	Ki	nM	310.0
	23290702	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)c1		CHEMBL346829	=	Ki	nM	950.0	CHEMBL3981	Homo sapiens	Ki	nM	950.0
	23290703	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cccc(C2=C(Nc3ccc(SC)cc3)C(=O)NC2=O)c1		CHEMBL158526	=	Ki	nM	3500.0	CHEMBL3981	Homo sapiens	Ki	nM	3500.0
	23290704	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cccc(C2=C(Nc3cccc(O)c3)C(=O)NC2=O)c1		CHEMBL160373	=	Ki	nM	4100.0	CHEMBL3981	Homo sapiens	Ki	nM	4100.0
	23290705	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccccc1		CHEMBL347647	=	Ki	nM	560.0	CHEMBL3981	Homo sapiens	Ki	nM	560.0
	23290706	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	CSc1ccccc1NC1=C(c2ccccc2C(F)(F)F)C(=O)NC1=O		CHEMBL4859332	=	Ki	nM	26000.0	CHEMBL3981	Homo sapiens	Ki	nM	26000.0
	23290707	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	CSc1ccccc1NC1=C(c2ccccc2Cl)C(=O)NC1=O		CHEMBL4860677	=	Ki	nM	12000.0	CHEMBL3981	Homo sapiens	Ki	nM	12000.0
	23290708	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccccc2SC)C(=O)NC1=O		CHEMBL4878043	=	Ki	nM	1300.0	CHEMBL3981	Homo sapiens	Ki	nM	1300.0
	23290709	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	CSc1cccc(NC2=C(c3ccccc3C(F)(F)F)C(=O)NC2=O)c1		CHEMBL4860051	=	Ki	nM	730.0	CHEMBL3981	Homo sapiens	Ki	nM	730.0
	23290710	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	CSc1cccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)c1		CHEMBL4858023	=	Ki	nM	340.0	CHEMBL3981	Homo sapiens	Ki	nM	340.0
	23290711	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(SC)c2)C(=O)NC1=O		CHEMBL4857159	=	Ki	nM	110.0	CHEMBL3981	Homo sapiens	Ki	nM	110.0
	23290712	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	CSc1ccc(NC2=C(c3ccccc3C(F)(F)F)C(=O)NC2=O)cc1		CHEMBL4869099	=	Ki	nM	3200.0	CHEMBL3981	Homo sapiens	Ki	nM	3200.0
	23290713	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc(SC)cc2)C(=O)NC1=O		CHEMBL349540	=	Ki	nM	140.0	CHEMBL3981	Homo sapiens	Ki	nM	140.0
	23290714	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	CS(=O)(=O)c1cccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)c1		CHEMBL4848515	=	Ki	nM	2300.0	CHEMBL3981	Homo sapiens	Ki	nM	2300.0
	23290715	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(S(C)(=O)=O)c2)C(=O)NC1=O		CHEMBL4877795	=	Ki	nM	630.0	CHEMBL3981	Homo sapiens	Ki	nM	630.0
	23290716	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2C(F)(F)F)=C1Nc1cccc(O)c1		CHEMBL4855533	=	Ki	nM	3400.0	CHEMBL3981	Homo sapiens	Ki	nM	3400.0
	23290717	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Ki	nM	560.0	CHEMBL3981	Homo sapiens	Ki	nM	560.0
	23290718	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2C(F)(F)F)=C1Nc1ccc(O)cc1		CHEMBL4876241	=	Ki	nM	2200.0	CHEMBL3981	Homo sapiens	Ki	nM	2200.0
	23290719	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccc(O)cc1		CHEMBL347702	=	Ki	nM	300.0	CHEMBL3981	Homo sapiens	Ki	nM	300.0
	23290720	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc(O)cc2)C(=O)NC1=O		CHEMBL160338	=	Ki	nM	200.0	CHEMBL3981	Homo sapiens	Ki	nM	200.0
	23290721	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2C(F)(F)F)=C1Nc1cccc(F)c1		CHEMBL4875281	=	Ki	nM	2100.0	CHEMBL3981	Homo sapiens	Ki	nM	2100.0
	23290722	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(F)c1		CHEMBL4878748	=	Ki	nM	380.0	CHEMBL3981	Homo sapiens	Ki	nM	380.0
	23290723	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(F)c2)C(=O)NC1=O		CHEMBL4855513	=	Ki	nM	76.0	CHEMBL3981	Homo sapiens	Ki	nM	76.0
	23290724	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(C(F)(F)F)c1		CHEMBL4855321	=	Ki	nM	1500.0	CHEMBL3981	Homo sapiens	Ki	nM	1500.0
	23290725	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(C(F)(F)F)c2)C(=O)NC1=O		CHEMBL4847807	=	Ki	nM	340.0	CHEMBL3981	Homo sapiens	Ki	nM	340.0
	23290726	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2C(F)(F)F)=C1Nc1cccc(Cl)c1		CHEMBL4848852	=	Ki	nM	960.0	CHEMBL3981	Homo sapiens	Ki	nM	960.0
	23290727	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	Ki	nM	46.0	CHEMBL3981	Homo sapiens	Ki	nM	46.0
	23290728	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2C(F)(F)F)=C1Nc1ccc(O)c(Cl)c1		CHEMBL4851803	=	Ki	nM	610.0	CHEMBL3981	Homo sapiens	Ki	nM	610.0
	23290729	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccc(O)c(Cl)c1		CHEMBL157141	=	Ki	nM	150.0	CHEMBL3981	Homo sapiens	Ki	nM	150.0
	23290730	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2C(F)(F)F)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL4852595	=	Ki	nM	9300.0	CHEMBL3981	Homo sapiens	Ki	nM	9300.0
	23290731	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Ki	nM	2300.0	CHEMBL3981	Homo sapiens	Ki	nM	2300.0
	23290732	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cc(Cl)c(O)c(Cl)c2)C(=O)NC1=O		CHEMBL345800	=	Ki	nM	590.0	CHEMBL3981	Homo sapiens	Ki	nM	590.0
	23290733	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(CNC2=C(c3ccccc3C(F)(F)F)C(=O)NC2=O)cc1Cl	Outside typical range	CHEMBL4847117	=	Ki	nM	130000.0	CHEMBL3981	Homo sapiens	Ki	nM	130000.0
	23290734	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(CNC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1Cl	Outside typical range	CHEMBL4872236	=	Ki	nM	190000.0	CHEMBL3981	Homo sapiens	Ki	nM	190000.0
	23290735	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(CNC2=C(c3ccccc3OC)C(=O)NC2=O)cc1Cl	Outside typical range	CHEMBL4866228	=	Ki	nM	450000.0	CHEMBL3981	Homo sapiens	Ki	nM	450000.0
	23290736	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	N#Cc1cccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)c1		CHEMBL4848202	=	Ki	nM	350.0	CHEMBL3981	Homo sapiens	Ki	nM	350.0
	23290737	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	Ki	nM	26.0	CHEMBL3981	Homo sapiens	Ki	nM	26.0
	23290738	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	N#Cc1cccc(NC2=C(c3ccccc3Oc3ccccc3)C(=O)NC2=O)c1		CHEMBL4877169	=	Ki	nM	33000.0	CHEMBL3981	Homo sapiens	Ki	nM	33000.0
Not Determined	23290739	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	N#Cc1cccc(NC2=C(c3ccc(Oc4ccccc4)cc3)C(=O)NC2=O)c1		CHEMBL4855933		Ki			CHEMBL3981	Homo sapiens	Ki		
	23290740	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	N#Cc1cccc(NC2=C(c3cccc4ccccc34)C(=O)NC2=O)c1		CHEMBL4877101	=	Ki	nM	110.0	CHEMBL3981	Homo sapiens	Ki	nM	110.0
	23290741	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1NC1=C(c2ccccc2OC)C(=O)NC1=O		CHEMBL4862897	=	Ki	nM	1500.0	CHEMBL3981	Homo sapiens	Ki	nM	1500.0
	23290742	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cccc(NC2=C(c3ccccc3OC)C(=O)NC2=O)c1		CHEMBL4847820	=	Ki	nM	180.0	CHEMBL3981	Homo sapiens	Ki	nM	180.0
	23290743	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(NC2=C(c3ccccc3OC)C(=O)NC2=O)cc1		CHEMBL4852101	=	Ki	nM	120.0	CHEMBL3981	Homo sapiens	Ki	nM	120.0
	23290744	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(NC2=C(c3ccccc3OC)C(=O)NC2=O)c(OC)c1		CHEMBL4870064	=	Ki	nM	2400.0	CHEMBL3981	Homo sapiens	Ki	nM	2400.0
	23290745	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(NC2=C(c3ccccc3OC)C(=O)NC2=O)cc1OC		CHEMBL4876004	=	Ki	nM	1100.0	CHEMBL3981	Homo sapiens	Ki	nM	1100.0
	23290746	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(NC2=C(c3ccccc3OC)C(=O)NC2=O)cc(OC)c1		CHEMBL4848740	=	Ki	nM	480.0	CHEMBL3981	Homo sapiens	Ki	nM	480.0
	23290747	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc3c(c2)OCO3)C(=O)NC1=O		CHEMBL4869745	=	Ki	nM	84.0	CHEMBL3981	Homo sapiens	Ki	nM	84.0
	23290748	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc(N3CCOCC3)cc2)C(=O)NC1=O		CHEMBL4854271	=	Ki	nM	460.0	CHEMBL3981	Homo sapiens	Ki	nM	460.0
	23290749	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc3ccccc23)C(=O)NC1=O		CHEMBL4877889	=	Ki	nM	47.0	CHEMBL3981	Homo sapiens	Ki	nM	47.0
	23290750	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc(-c3ccccc3)cc2)C(=O)NC1=O		CHEMBL4851482	=	Ki	nM	320.0	CHEMBL3981	Homo sapiens	Ki	nM	320.0
	23290751	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2nc3ccccc3s2)C(=O)NC1=O		CHEMBL4871036	=	Ki	nM	7300.0	CHEMBL3981	Homo sapiens	Ki	nM	7300.0
	23290752	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc(C(=O)c3ccccc3)cc2)C(=O)NC1=O		CHEMBL4876254	=	Ki	nM	600.0	CHEMBL3981	Homo sapiens	Ki	nM	600.0
	23290753	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc(Nc3ccccc3)cc2)C(=O)NC1=O		CHEMBL4873631	=	Ki	nM	1200.0	CHEMBL3981	Homo sapiens	Ki	nM	1200.0
	23290754	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(-c3ccsc3)c2)C(=O)NC1=O		CHEMBL4855633	=	Ki	nM	640.0	CHEMBL3981	Homo sapiens	Ki	nM	640.0
	23290755	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc(-c3ccsc3)cc2)C(=O)NC1=O		CHEMBL4863077	=	Ki	nM	400.0	CHEMBL3981	Homo sapiens	Ki	nM	400.0
	23290756	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(C(C)(C)C)c2)C(=O)NC1=O		CHEMBL4865401	=	Ki	nM	5500.0	CHEMBL3981	Homo sapiens	Ki	nM	5500.0
	23290757	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(OCc3ccccc3)c2)C(=O)NC1=O		CHEMBL4879311	=	Ki	nM	3200.0	CHEMBL3981	Homo sapiens	Ki	nM	3200.0
	23290758	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc(OCc3ccccc3)c(Cl)c2)C(=O)NC1=O		CHEMBL4859423	=	Ki	nM	790.0	CHEMBL3981	Homo sapiens	Ki	nM	790.0
	23290759	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2ccc3ncccc3c2)C(=O)NC1=O		CHEMBL4868821	=	Ki	nM	110.0	CHEMBL3981	Homo sapiens	Ki	nM	110.0
	23290760	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc3cccnc23)C(=O)NC1=O		CHEMBL4871372	=	Ki	nM	1500.0	CHEMBL3981	Homo sapiens	Ki	nM	1500.0
	23290761	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccccc1C1=C(Nc2cccc(-c3ccc(F)cc3)c2)C(=O)NC1=O		CHEMBL4874184	=	Ki	nM	6900.0	CHEMBL3981	Homo sapiens	Ki	nM	6900.0
	23290762	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(-c2ccccc2)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4852765	=	Ki	nM	3000.0	CHEMBL3981	Homo sapiens	Ki	nM	3000.0
	23290763	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(-c2ccccc2)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4869281	=	Ki	nM	320.0	CHEMBL3981	Homo sapiens	Ki	nM	320.0
Not Determined	23290764	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(-c2ccc(OCc3ccccc3)c(F)c2)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4873036		Ki			CHEMBL3981	Homo sapiens	Ki		
	23290765	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(-c2ccc(OCc3ccccc3)c(F)c2)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875291	=	Ki	nM	2000.0	CHEMBL3981	Homo sapiens	Ki	nM	2000.0
	23290766	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(-c2cccc3c2OCCO3)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4855005	=	Ki	nM	4600.0	CHEMBL3981	Homo sapiens	Ki	nM	4600.0
	23290767	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(-c2cccc3c2OCCO3)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4857914	=	Ki	nM	4600.0	CHEMBL3981	Homo sapiens	Ki	nM	4600.0
Not Determined	23290768	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(-c2cc(OC)c(OC)c(OC)c2)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4848444		Ki			CHEMBL3981	Homo sapiens	Ki		
	23290769	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(-c2cc(OC)c(OC)c(OC)c2)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4864305	=	Ki	nM	3700.0	CHEMBL3981	Homo sapiens	Ki	nM	3700.0
	23290770	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(-c2ccsc2)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875006	=	Ki	nM	540.0	CHEMBL3981	Homo sapiens	Ki	nM	540.0
	23290771	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(-c2ccsc2)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4870533	=	Ki	nM	1100.0	CHEMBL3981	Homo sapiens	Ki	nM	1100.0
	23290772	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(-c2cccnc2)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4852451	=	Ki	nM	440.0	CHEMBL3981	Homo sapiens	Ki	nM	440.0
	23290773	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(-c2cccnc2)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4869999	=	Ki	nM	1900.0	CHEMBL3981	Homo sapiens	Ki	nM	1900.0
	23290774	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(-c2ccc(Cl)nc2Cl)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4845800	=	Ki	nM	320.0	CHEMBL3981	Homo sapiens	Ki	nM	320.0
	23290775	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(NC(=O)C(C)C)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4867952	=	Ki	nM	88.0	CHEMBL3981	Homo sapiens	Ki	nM	88.0
Not Determined	23290776	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(NC(=O)C(C)C)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4866676		Ki			CHEMBL3981	Homo sapiens	Ki		
	23290777	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1cc(Br)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4878325	=	Ki	nM	35.0	CHEMBL3981	Homo sapiens	Ki	nM	35.0
	23290778	CHEMBL4839427	Binding affinity human STK10 by binding displacement assay	B	COc1ccc(Br)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4856751	=	Ki	nM	61.0	CHEMBL3981	Homo sapiens	Ki	nM	61.0
	23290863	CHEMBL4839430	Inhibition of STK10 (unknown origin) expressed in Sf9 cells assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	IC50	nM	12.0	CHEMBL3981	Homo sapiens	IC50	nM	12.0
	23290864	CHEMBL4839430	Inhibition of STK10 (unknown origin) expressed in Sf9 cells assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	IC50	nM	23.0	CHEMBL3981	Homo sapiens	IC50	nM	23.0
	23290865	CHEMBL4839430	Inhibition of STK10 (unknown origin) expressed in Sf9 cells assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccccc1C1=C(Nc2cccc3ccccc23)C(=O)NC1=O		CHEMBL4877889	=	IC50	nM	1420.0	CHEMBL3981	Homo sapiens	IC50	nM	1420.0
	23290866	CHEMBL4839430	Inhibition of STK10 (unknown origin) expressed in Sf9 cells assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1cc(Br)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4878325	=	IC50	nM	60.0	CHEMBL3981	Homo sapiens	IC50	nM	60.0
	23290867	CHEMBL4839430	Inhibition of STK10 (unknown origin) expressed in Sf9 cells assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccc(Br)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4856751	=	IC50	nM	99.0	CHEMBL3981	Homo sapiens	IC50	nM	99.0
	23290868	CHEMBL4839430	Inhibition of STK10 (unknown origin) expressed in Sf9 cells assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	IC50	nM	99.0	CHEMBL3981	Homo sapiens	IC50	nM	99.0
	23290896	CHEMBL4839443	Inhibition of human STK10 assessed as residual percent of control by Kinomescan method relative to control	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	Activity	%	16.0	CHEMBL3981	Homo sapiens	Activity	%	16.0
	23290897	CHEMBL4839443	Inhibition of human STK10 assessed as residual percent of control by Kinomescan method relative to control	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	Activity	%	7.3	CHEMBL3981	Homo sapiens	Activity	%	7.3
	23290923	CHEMBL4839456	Inhibition of biotinylated full-length STK10 expressed in Escherichia coli DH10Bac assessed as transfer of radiolabelled phosphate from ATP by OMNIA enzymatic assay	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	IC50	nM	1500.0	CHEMBL3981	Homo sapiens	IC50	uM	1.5
	23290924	CHEMBL4839456	Inhibition of biotinylated full-length STK10 expressed in Escherichia coli DH10Bac assessed as transfer of radiolabelled phosphate from ATP by OMNIA enzymatic assay	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	IC50	nM	1400.0	CHEMBL3981	Homo sapiens	IC50	uM	1.4
	23290925	CHEMBL4839456	Inhibition of biotinylated full-length STK10 expressed in Escherichia coli DH10Bac assessed as transfer of radiolabelled phosphate from ATP by OMNIA enzymatic assay	B	COc1ccccc1C1=C(Nc2cccc3ccccc23)C(=O)NC1=O		CHEMBL4877889	>	IC50	nM	20000.0	CHEMBL3981	Homo sapiens	IC50	uM	20.0
	23290926	CHEMBL4839456	Inhibition of biotinylated full-length STK10 expressed in Escherichia coli DH10Bac assessed as transfer of radiolabelled phosphate from ATP by OMNIA enzymatic assay	B	COc1cc(Br)ccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4878325	=	IC50	nM	4400.0	CHEMBL3981	Homo sapiens	IC50	uM	4.4
	23290927	CHEMBL4839456	Inhibition of biotinylated full-length STK10 expressed in Escherichia coli DH10Bac assessed as transfer of radiolabelled phosphate from ATP by OMNIA enzymatic assay	B	COc1ccc(Br)cc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4856751	=	IC50	nM	4500.0	CHEMBL3981	Homo sapiens	IC50	uM	4.5
Not Active	23317477	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	76.0	CHEMBL3981	Homo sapiens	% Control	%	76.0
Not Active	23317945	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	73.0	CHEMBL3981	Homo sapiens	% Control	%	73.0
Not Active	23318612	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23319095	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23319732	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23320207	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	82.4	CHEMBL3981	Homo sapiens	% Control	%	82.4
Not Active	23320885	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23321353	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	87.0	CHEMBL3981	Homo sapiens	% Control	%	87.0
Not Active	23321983	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	97.0	CHEMBL3981	Homo sapiens	% Control	%	97.0
Not Active	23322451	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	98.0	CHEMBL3981	Homo sapiens	% Control	%	98.0
Not Active	23323140	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	88.0	CHEMBL3981	Homo sapiens	% Control	%	88.0
Not Active	23323608	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23324047	CHEMBL4880666	LOK (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	26.0	CHEMBL3981	Homo sapiens	% inhibition	%	26.0
Not Active	23324462	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23325097	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23325565	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	84.0	CHEMBL3981	Homo sapiens	% Control	%	84.0
Not Active	23326212	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	65.0	CHEMBL3981	Homo sapiens	% Control	%	65.0
Not Active	23326680	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	69.0	CHEMBL3981	Homo sapiens	% Control	%	69.0
Not Active	23327380	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	54.0	CHEMBL3981	Homo sapiens	% Control	%	54.0
Not Active	23327848	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	94.0	CHEMBL3981	Homo sapiens	% Control	%	94.0
Not Active	23328435	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	79.0	CHEMBL3981	Homo sapiens	% Control	%	79.0
Not Active	23328903	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	88.0	CHEMBL3981	Homo sapiens	% Control	%	88.0
Not Active	23329397	CHEMBL4881104	LOK(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	114.0	CHEMBL3981	Homo sapiens	% residual kinase activity	%	114.0
Not Active	23329849	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	52.0	CHEMBL3981	Homo sapiens	% Control	%	52.0
Not Active	23330317	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	96.0	CHEMBL3981	Homo sapiens	% Control	%	96.0
Not Active	23331073	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23331541	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Slightly Active	23331877	CHEMBL4881417	KINOMEScan (DiscoveRx Corp) with STK10	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		Kd	nM	5.9	CHEMBL3981	Homo sapiens	Kd	nM	5.9
Not Active	23331889	CHEMBL4881429	NanoBRET assay (SGC) with STK10	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		IC50	nM	210.0	CHEMBL3981	Homo sapiens	IC50	nM	210.0
Not Active	23331897	CHEMBL4881437	NanoBRET assay (SGC) with STK10	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1	Non standard unit for type	CHEMBL4526351	>	IC50	µM	10.0	CHEMBL3981	Homo sapiens	IC50	µM	10.0
Active	23332128	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	1.8	CHEMBL3981	Homo sapiens	% Control	%	1.8
Slightly Active	23332594	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	26.8	CHEMBL3981	Homo sapiens	% Control	%	26.8
Not Active	23333312	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	84.5	CHEMBL3981	Homo sapiens	% Control	%	84.5
Not Active	23333951	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	95.0	CHEMBL3981	Homo sapiens	% Control	%	95.0
Not Active	23334419	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23335398	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23335866	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23336493	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23336961	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23338042	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	89.0	CHEMBL3981	Homo sapiens	% Control	%	89.0
Not Active	23338510	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23339122	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23339590	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23340227	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	99.0	CHEMBL3981	Homo sapiens	% Control	%	99.0
Not Active	23340695	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23341352	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	94.0	CHEMBL3981	Homo sapiens	% Control	%	94.0
Not Active	23341820	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23342436	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23342904	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	89.0	CHEMBL3981	Homo sapiens	% Control	%	89.0
Not Active	23343534	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23344002	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	80.0	CHEMBL3981	Homo sapiens	% Control	%	80.0
Not Active	23344640	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23345213	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23345681	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	99.0	CHEMBL3981	Homo sapiens	% Control	%	99.0
Not Active	23346258	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23346726	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	74.5	CHEMBL3981	Homo sapiens	% Control	%	74.5
Not Active	23347328	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	84.8	CHEMBL3981	Homo sapiens	% Control	%	84.8
Not Active	23347818	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	95.5	CHEMBL3981	Homo sapiens	% Control	%	95.5
Not Active	23348397	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23348865	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23349452	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23350070	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23350538	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23351143	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23351611	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23352635	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	83.0	CHEMBL3981	Homo sapiens	% Control	%	83.0
Not Active	23353103	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	91.0	CHEMBL3981	Homo sapiens	% Control	%	91.0
Not Active	23353985	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23354453	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23355185	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23355653	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23356289	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23356757	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23357366	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	89.0	CHEMBL3981	Homo sapiens	% Control	%	89.0
Not Active	23358013	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	74.0	CHEMBL3981	Homo sapiens	% Control	%	74.0
Not Active	23358481	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	94.0	CHEMBL3981	Homo sapiens	% Control	%	94.0
Not Active	23359067	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	67.8	CHEMBL3981	Homo sapiens	% Control	%	67.8
Not Active	23359665	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23360133	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	86.0	CHEMBL3981	Homo sapiens	% Control	%	86.0
Not Active	23360718	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	94.0	CHEMBL3981	Homo sapiens	% Control	%	94.0
Not Active	23361186	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23361759	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23362295	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23362763	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23364405	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	74.0	CHEMBL3981	Homo sapiens	% Control	%	74.0
Not Active	23364873	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23365612	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23366155	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	88.0	CHEMBL3981	Homo sapiens	% Control	%	88.0
Not Active	23366745	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23367213	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23368091	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	94.0	CHEMBL3981	Homo sapiens	% Control	%	94.0
Not Active	23368559	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23369158	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	86.0	CHEMBL3981	Homo sapiens	% Control	%	86.0
Not Active	23369626	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	54.0	CHEMBL3981	Homo sapiens	% Control	%	54.0
Not Active	23370118	CHEMBL4884362	LOK(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	88.0	CHEMBL3981	Homo sapiens	% residual kinase activity	%	88.0
Not Active	23370594	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23371062	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	68.0	CHEMBL3981	Homo sapiens	% Control	%	68.0
Not Active	23371871	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23372339	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23375375	CHEMBL4886357	serine/threonine kinase 10 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	0.0	CHEMBL3981	Homo sapiens	% inhibition	%	0.0
Not Active	23375766	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23376234	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23376811	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	99.0	CHEMBL3981	Homo sapiens	% Control	%	99.0
Not Active	23377279	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23378139	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23378607	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	92.0	CHEMBL3981	Homo sapiens	% Control	%	92.0
Not Active	23379774	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23380242	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	95.0	CHEMBL3981	Homo sapiens	% Control	%	95.0
Not Active	23380936	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23381584	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23382052	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23382676	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	77.0	CHEMBL3981	Homo sapiens	% Control	%	77.0
Not Active	23383144	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23384329	CHEMBL4887924	LOK(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	8.13	CHEMBL3981	Homo sapiens	% inhibition	%	8.13
Not Active	23385059	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL3981	Homo sapiens	% Control	%	100.0
Not Active	23385526	CHEMBL4879783	KinomeScan assay: inhibition of LOK	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	98.0	CHEMBL3981	Homo sapiens	% Control	%	98.0
